https://www.dailyhealthindustry.it/nuovi-farmaci-2016-anno-fiacco-fda-ne-ha-approvati-solo-20/ 2016-12-15T15:56:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/degenerazione-maculare-fallisce-combo-lucentis-fovista/ 2020-11-10T08:33:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-a-origgio-nuova-linea-produzione-enterogermina/ 2016-12-15T17:58:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-novartis-compra-ziarco-per-rafforzare-la-dermatologia/ 2020-11-10T08:33:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diagnostica-siemens-investe-300-mln-di-dollari-per-potenziare-produzione/ 2016-12-16T13:49:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-e-sviluppo-roi-ancora-in-calo-big-pharma-si-ferma-al-37-per-cento/ 2016-12-16T17:28:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-merck-vince-causa-contro-gilead-in-usa/ 2016-12-16T17:44:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genomica-roche-abbandona-partnership-con-pacbio/ 2016-12-16T14:46:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/witty-ceo-gsk-il-futuro-e-nei-vaccini/ 2016-12-16T17:26:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csr-per-zoetis-natale-solidale-con-la-comunita-di-santegidio-e-le-zone-terremotate/ 2016-12-19T10:35:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-melazzini-aifa-fast-track-valore-per-la-sperimentazione/ 2016-12-19T16:35:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-accordo-con-sanofi-sotto-labero/ 2016-12-19T16:48:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-polmone-da-chmp-si-a-keytruda-msd-come-trattamento-di-prima-linea/ 2020-11-10T08:33:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diagnostica-ce-approva-kit-per-tumori-endocrini-di-advanced-accelerator-applications/ 2016-12-19T13:50:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-tutti-gli-uomini-del-presidente-per-fda-scott-gottlieb-in-pole-position/ 2016-12-19T17:27:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-previsioni-in-crescita-per-il-2023-gli-analisti-conquistera-gli-investitori/ 2016-12-19T17:31:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-report-aifa-deficit-di-quasi-due-mld-di-euro/ 2016-12-20T18:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-ema-screening-per-la-b-prima-di-assumere-nuovi-antivirali/ 2016-12-20T10:37:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diagnostica-menarini-acquista-tecnologia-da-janssen-diagnostics-per-analisi-ctc/ 2016-12-20T17:19:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-neurodegenerative-accordo-celegene-evotec-per-screening-farmaci/ 2020-11-10T08:33:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/steatosi-epatica-novartis-sviluppera-nuovo-farmaco-con-biotech-usa/ 2020-11-10T08:33:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-per-botox-un-futuro-da-antidepressivo/ 2020-11-10T08:33:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-in-italia-58-mila-apparecchiature-diagnostiche-obsolete/ 2016-12-20T15:04:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-bene-la-combo-a-due-farmaci-di-gsk-approvazione-gia-nel-2017/ 2020-11-10T08:33:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-arriva-in-usa-basaglar-biosimilare-dellinsulina-lantus/ 2020-11-10T08:33:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-bms-sviluppera-virus-oncolitico-con-biotech-britannica/ 2020-11-10T08:33:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-leadership-business-oriented-il-nuovo-ceo-e-il-direttore-commerciale/ 2016-12-21T15:32:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-continua-lo-shopping-acquisita-encore-vision/ 2020-11-10T08:33:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-gilead-guida-la-ricerca-sullinibizione-delle-mmp/ 2016-12-21T17:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-italia-marco-de-luigi-nuovo-presidente-e-ad/ 2016-12-22T11:12:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-nasce-in-italia-sanofi-pasteur-la-guidera-mario-merlo/ 2016-12-22T12:58:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-accordo-almirall-mercachem-per-sviluppo-inibitori-citochine/ 2020-11-10T08:30:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fusioni-e-acquisizioni-che-anno-sara/ 2016-12-22T14:36:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-fast-track-dallfda-per-vaccino-contro-allergia-alle-arachidi/ 2020-11-10T08:30:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-e-cosmetica-in-italia-crescono-i-volumi-daffari/ 2016-12-22T15:58:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2017-biosimilari-alla-prova-del-mercato-americano/ 2016-12-23T13:04:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-compre-lifecell-e-si-rafforza-nella-medicina-rigenerativa/ 2016-12-23T13:16:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-st-jude-medical-via-libera-dallantitrust-usa/ 2016-12-23T13:38:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-come-e-quanto-cambiera-il-biotech/ 2016-12-23T13:46:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arriva-in-italia-la-prima-chatbot-per-i-medici/ 2016-12-23T15:10:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-st-jude-medical-ce-lok-della-ftc-accordo-a-25-miliardi-di-dollari/ 2016-12-28T13:08:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lanno-che-verra-il-2017-allinsegna-del-biotech/ 2017-01-07T10:36:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governo-davide-faraone-e-il-nuovo-sottosegretario-alla-salute/ 2016-12-29T14:28:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-boehringer-ingelheim-asset-swap-per-135-mld-di-dollari/ 2016-12-30T13:36:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologici-luci-e-ombre-in-uno-studio-su-jama-oncology/ 2017-01-03T12:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/equivalenza-terapeutica-sif-bene-marcia-indietro-aifa-su-determina-458/ 2017-01-04T13:15:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-jj-rilancia-260-dollari-per-azione-e-spin-off-nuova-azienda/ 2017-01-07T10:34:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-st-jude-medical-e-fatta-raggiunto-laccordo/ 2017-01-09T10:03:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-aifa-crescono-gli-studi-clinici-flessione-per-il-pharma-made-in-italy/ 2017-01-09T10:14:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-presto-menisco-artificiale-da-stampanti-3d/ 2017-01-09T17:33:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiovascolare-novartis-si-assicura-due-candidati-biotech/ 2020-11-10T08:30:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-parte-sperimentazione-combo-bms-johnson-johnson/ 2020-11-10T08:30:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-i-vaccini-entrano-nel-portafoglio-prodotti/ 2020-11-10T08:30:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-market-access-e-morto-viva-il-patient-access/ 2020-11-10T08:24:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-per-il-2017-previsioni-al-ribasso/ 2020-11-10T08:30:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-nominati-i-vertici-poggio-nuovo-ad-chiassarini-presidente/ 2020-11-10T08:51:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-autoimmuni-celgene-in-corsa-per-startup-svizzera/ 2020-11-10T08:30:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genomica-accordo-ibm-e-illumina-per-sistema-watson/ 2017-01-10T15:05:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-forecast-conservativo-per-il-2017/ 2017-01-10T15:33:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-chi-ha-vinto-e-chi-ha-perso-nel-2016/ 2017-01-10T18:23:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-cardiaci-abbott-lancia-software-patch-per-defibrillatori-st-jude-medical/ 2017-01-10T16:46:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-spot-humira-abbvie-star-della-tv-usa/ 2017-01-11T17:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-jlabs-a-new-york-entro-il-2018/ 2017-01-11T13:38:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-pomone-speedy-review-di-fda-a-combo-keytruda-chemioterapia/ 2020-11-10T08:30:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-forecast-2017-a-gonfie-vele-ricavi-a-oltre-21-mld-di-dollari-per-il-2020/ 2017-01-11T15:06:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/appropriatezza-lancet-disegna-la-mappa-mondiale/ 2017-01-11T15:26:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-cambia-il-vertice-usa-20-nuovi-farmaci-entro-il-2023/ 2017-01-11T16:39:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-al-momento-nessun-accordo-focus-su-hiv-e-nash/ 2020-11-10T08:30:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-a-big-pharma-usa-la-state-facendo-franca/ 2017-01-12T15:32:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-acquista-4-programmi-oncologici-da-vertex/ 2020-11-10T08:30:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-5-mld-di-dollari-a-maverick-per-lavorare-su-piattaforma-t-cell/ 2017-01-13T11:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-pfizer-lancia-un-contest-per-la-gestione-delle-pazienti-con-metastasi/ 2017-01-12T18:58:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nel-2017-aumento-prezzi-sotto-il-10-per-cento/ 2017-01-12T19:11:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-fabio-mazzotta-nuovo-general-manager-della-bu-consumer-healthcare/ 2017-01-12T18:50:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-il-25-gennaio-nuovo-consiglio-direttivo-flavia-bustreo-candidata-dg/ 2017-01-13T17:10:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parita-di-genere-prezzi-dei-farmaci-biotech-il-2017-del-pharma-in-usa/ 2017-01-13T14:57:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-giappone-cina-europa-il-risiko-del-pharma-nel-2017/ 2017-01-13T16:26:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-johnson-johnson-e-a-un-passo/ 2017-01-13T15:10:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trial-clinici-il-nuovo-ruolo-dei-pazienti/ 2017-01-13T15:59:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-novartis-alla-ricerca-di-nuovi-partner-tech/ 2017-01-13T17:16:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-merck-first-mover-il-mercato-ci-crede/ 2017-01-16T13:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/automedicazione-melazzini-aifa-e-una-risorsa-ma-e-necessaria-informazione/ 2017-01-16T12:47:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colonna-vertebrale-da-philips-piattaforma-3d-per-i-chirurghi/ 2017-01-16T17:02:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-igheleim-focus-su-malattie-croniche-dopo-asset-swap-con-sanofi/ 2020-11-10T08:30:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genzyme-per-dupilumab-un-futuro-da-targeted-therapy/ 2020-11-10T08:30:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-addio-allobamacare-quale-sara-la-sanita-di-trump/ 2017-01-16T17:07:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-aifa-agcm-collaborazione-a-tutto-campo/ 2017-01-17T12:07:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-contro-il-cancro-bavarian-nordic-ci-crede-e-collabora-con-bms/ 2017-01-17T14:02:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saunders-allergan-il-2017-saro-lanno-di-kybella/ 2020-11-10T08:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-ceylad-mette-la-freccia-sui-tumori-solidi/ 2020-11-10T08:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colesterolo-dopo-le-statine-ce-lacido-bempedoico/ 2017-01-17T17:04:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-trump-vuole-al-vertice-un-manager-della-silicon-valley/ 2017-01-17T17:15:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-alessandro-riva-a-capo-della-ricerca-in-ematologia-e-oncologia/ 2017-01-18T11:51:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-export-farmaceutica-gioiello-del-paese/ 2017-01-18T12:02:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-un-business-che-nel-2022-arrivera-a-90-mld-di-dollari/ 2017-01-18T13:15:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-cresce-in-turchia-e-apre-nuovo-headquarter-a-istanbul/ 2017-01-18T15:37:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scadenza-brevetti-ecco-i-blockbuster-a-rischio/ 2017-01-25T08:39:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-al-via-sperimentazione-tendine-artificiale-con-jj/ 2017-01-18T16:38:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-via-libera-da-ce-a-suliqua-sanofi/ 2020-11-10T08:30:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/niente-delocalizzazione-e-invstimenti-in-usa-le-promesse-di-bayer-a-trump/ 2017-01-19T13:44:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-agcm-firmano-protocollo-dintesa/ 2017-01-19T15:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-fda-apre-allintercambiabilita-senza-parere-medico/ 2017-01-19T15:18:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapia-del-dolore-lilly-acquisisce-colucid-per-candidato-first-in-class/ 2020-11-10T08:30:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nel-2016-approvati-81-farmaci/ 2017-01-19T16:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-avvicendamento-ai-vertici-hussain-lascia-e-arriva-miels-da-astrazeneca/ 2017-01-20T11:41:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-prenatali-un-mercato-da-2-mld-di-dollari/ 2017-01-20T13:28:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-ok-fda-a-rhofade-allergan/ 2020-11-10T08:30:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epilessia-accordo-takeda-biotech-di-ny-per-sviluppo-candidato/ 2020-11-10T08:30:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-e-se-il-governo-usa-comprasse-gilead/ 2017-01-20T15:46:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/social-media-e-sanita-verso-la-tempesta-perfetta/ 2017-01-20T16:09:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-polmone-bms-niente-accelerated-approval-per-combo-opdivoyervoy/ 2017-01-23T11:00:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-italiane-il-2016-chiude-a-252-mld-bene-gli-integratori-tiene-la-cosmesi/ 2017-01-23T11:32:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-governi-no-profit-prove-di-dialogo-nasce-cepi/ 2017-01-23T14:55:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-biotech-e-biosimilari-i-primi-cento-giorni-di-trump/ 2017-01-23T16:11:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-ema-convalida-domanda-aic-per-triplice-terapia-gilead/ 2020-11-10T08:30:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-pfizer-astrazeneca-e-gsk-in-consorzio-con-cambridge/ 2017-01-23T16:59:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-integratori-italiani-fanno-bene-anche-allestero-il-rapporto-federsalus/ 2017-01-24T13:58:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-e-big-pharma-da-davos-le-voci-dei-ceo/ 2017-01-24T15:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sondaggio-big-pharma-piace-poco-agli-americani/ 2017-01-24T16:13:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/wtho-i-paesi-a-basso-reddito-possono-importare-i-farmaci-generici/ 2017-01-24T17:35:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-primo-ministro-may-collaborazione-trans-frontaliera-salvera-farmaceutica-britannica/ 2017-01-24T18:08:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-allineare-obiettivi-di-salute-pubblica-e-distribuzione-fondi-ricerca/ 2017-01-24T18:31:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-aumentano-le-vendite-ma-il-q4-non-raggiunge-le-stime/ 2017-01-25T17:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-sei-big-pharma-un-solo-login/ 2017-01-26T08:50:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tra-imaging-e-biopsie-liquide-ecco-il-2017-dei-medical-device/ 2017-01-25T17:38:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cresce-il-fronte-anti-vaccini-attesa-per-le-indicazioni-di-trump/ 2017-01-25T16:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-in-dieci-anni-lema-ha-concesso-30-cma/ 2017-01-25T17:03:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-accordo-sanofi-enteris-per-sviluppo-peptide-orale/ 2017-01-25T17:20:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q4-debole-ma-fiducia-dagli-analisti-si-valuta-cessione-di-alcon/ 2017-01-26T17:58:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-johnson-johnson-e-fatta-accordo-chiuso-a-30-mld-di-dollari/ 2017-01-26T17:55:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-ancora-poche-le-app-patient-centred/ 2020-11-10T08:24:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-usa-dopo-accuse-trump-via-a-campagna-mediatica/ 2017-01-26T17:09:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intuitive-surgical-vola-grazie-al-robot-da-vinci-ma-dal-2017-caleranno-le-vendite/ 2017-01-26T17:25:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-possibile-danno-epatico-sul-foglietto-illustrativo-di-tecfidera/ 2017-01-26T18:18:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/schizofrenia-litaliana-newron-punta-tutto-su-evenamide/ 2017-01-27T17:34:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-obiettivo-2017-recuperare-terreno-in-immuno-oncologia/ 2017-01-27T17:35:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-q4-tra-luci-e-ombre/ 2017-01-27T15:44:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-nuovi-positivi-dati-dalla-biotech-francese-cellectis/ 2017-01-27T17:21:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-sandoz-pronta-per-il-mercato-usa/ 2017-01-27T16:25:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/c-difficile-candidato-pfizer-arriva-a-fase-iii-ma-sanofi-e-in-vantaggio/ 2017-01-30T11:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-fda-approva-test-mnemonico-touchscreen/ 2017-01-30T12:26:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-punta-sulle-life-sciences-per-il-post-brexit/ 2017-01-30T16:59:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-le-terapie-orali-sorpassano-le-iniettive-attesa-per-ocrevus-roche/ 2017-01-30T14:10:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-merck-usa-pubblica-il-report-degli-ultimi-sette-anni/ 2017-01-30T15:51:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/snc-lundbeck-e-ossianix-insieme-per-superare-la-barriera-emato-encefalica/ 2020-11-10T08:30:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-reumatoide-ok-da-chmp-per-xeljanz-pfizer/ 2020-11-10T08:32:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ecco-la-top-ten-2017/ 2017-01-31T11:50:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-stop-immigrazione-biotech-usa-teme-perdita-di-talenti/ 2017-01-31T13:23:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-ok-in-usa-per-airduo-generico-di-advair-gsk/ 2020-11-10T08:32:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-ai-polmoni-partita-a-tre-fra-opdivo-tecentriq-e-keytruda/ 2020-11-10T08:32:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-europa-come-gli-usa/ 2017-01-31T17:40:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-polmone-ce-approva-keytruda-msd-come-trattamento-in-prima-linea/ 2017-02-01T09:49:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-si-espande-in-italia-ed-entra-in-akkadeas-pharma/ 2017-02-01T10:29:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-fatturato-2016-a-oltre-950-mln-di-euro/ 2017-02-01T10:58:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-a-big-pharma-riportate-la-produzione-in-usa/ 2017-02-01T15:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-q4-bene-per-vendite-ma-spese-troppo-alte/ 2017-02-01T16:19:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genetica-arriva-in-europa-veriseq-illumina/ 2017-02-01T16:26:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-con-aifa-e-antitrust-collaborazione-per-paese-competitivo/ 2017-02-01T18:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-cede-bu-delle-forniture-ospedaliere/ 2017-02-02T15:47:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-anche-takeda-nel-club-degli-aumenti-single-digit/ 2017-02-02T16:05:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q4-prevenar-frena/ 2017-02-02T17:13:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/poltrone-rick-fair-lascia-genentech-e-diventa-ceo-di-bellicum/ 2017-02-02T17:37:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/costi-e-fabbisogni-marche-umbria-e-veneto-regioni-benchmark-2017/ 2017-02-02T18:11:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-al-via-ledizione-2017-del-premio-galeno/ 2017-02-02T18:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiovascolare-repatha-amgen-raggiunge-gli-endopoint-in-due-studi/ 2017-02-03T11:27:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-investe-nella-ricerca-sul-microbioma-con-caelus/ 2017-02-03T15:59:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-trump-processi-regolatori-piu-snelli/ 2017-02-03T14:00:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-q4-sotto-le-stime-ma-bene-i-ricavi/ 2017-02-03T14:57:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-opdivo-bms-approvato-per-il-tumore-alla-vescica/ 2017-02-03T17:31:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dopo-brexit-si-lavora-per-un-sistema-a-due-vie/ 2017-02-03T15:51:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emofilia-shire-incidenza-tre-volte-superiore-alla-stima/ 2017-02-03T16:37:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-q4-a-gonfie-vele-nel-2017-la-sfida-dei-biosimilari/ 2017-02-06T14:02:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-sul-2017-pesa-lincognita-trump/ 2017-02-06T15:24:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-pancreas-buoni-risultati-per-il-primo-candidato-sviluppato-da-piattaforma/ 2017-02-06T15:47:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-portfolio-piu-snello-per-nuove-acqusizioni/ 2017-02-06T18:09:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoncologia-astrazeneca-lascia-combo-e-punta-su-durvalumab/ 2020-11-10T08:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-continua-emorragia-spesa-ospedaliera/ 2017-02-06T18:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-a-fine-marzo-arriva-emma-walmsley-ecco-le-sfide-che-lattendono/ 2017-02-07T15:06:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-si-e-dimesso-il-ceo-erez-vigodman/ 2017-02-07T15:23:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccinazioni-in-usa-avanza-il-partito-degli-scettici-cosa-fara-trump/ 2017-02-07T16:46:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-al-via-studio-clinico-con-due-endpoint-primari-per-approvazione-ema-e-fda/ 2020-11-10T08:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-azioni-in-calo-dopo-il-q4-acquisti-per-invertire-la-tendenza/ 2017-02-07T17:34:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iss-ecco-la-nuova-organizzazione/ 2017-02-07T17:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-zepatier-msd-da-oggi-anche-in-italia/ 2020-11-10T08:32:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zika-un-anno-dopo-oms-vaccino-non-prima-del-2020/ 2017-02-08T12:14:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-arriva-la-concorrenza-nellepatite-c/ 2017-02-08T13:41:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dialisi-fda-approva-parsabiv-amgen-per-complicanze-paratiroidee/ 2020-11-10T08:32:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cistite-interstiziale-due-aziende-italiane-in-partnership-per-farmaco-orfano/ 2017-02-08T14:40:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manager-italiano-do-you-speak-english-yes-intermediate/ 2017-02-08T14:57:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/risorse-umane-astrazeneca-italia-e-top-employer-2017/ 2017-02-08T17:28:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-per-il-ceo-brandicourt-il-2016-e-stato-un-anno-sfidante/ 2017-02-08T17:59:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-q4-positivo-primo-trimestre-2017-con-lincognita-aumento-dei-prezzi-usa/ 2017-02-09T13:55:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-testa-a-testa-tra-gsk-e-gilead-per-le-nuove-combo/ 2017-02-09T14:16:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-a-chiesi-la-distribuzione-esclusiva-dei-prodotti-antonetto-farmaceutici/ 2017-02-09T14:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-lundbeck-rinuncia-al-farmaco-sperimentale-idalopiridina/ 2017-02-09T15:16:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anticoagulanti-xarelto-bayer-efficace-anche-nelle-patologie-coronariche-e-periferiche/ 2020-11-10T08:32:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hr-merck-e-tra-le-top-employers-2017-italiane/ 2017-02-09T16:17:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-idea-novo-nordisk-la-sede-a-copenaghen/ 2017-02-10T13:24:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-duchenne-fda-approva-il-primo-steroide/ 2017-02-10T13:33:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/contraffazione-farmaci-scaccabarozzi-farmindustria-italia-paese-sicuro/ 2017-02-10T19:25:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/degenerazione-maculare-regeneron-abbassa-le-previsioni-per-eylea/ 2017-02-10T14:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-parte-il-progetto-biohub-di-zuckerberg/ 2017-02-10T15:15:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoncologia-a-big-pharma-piace-la-biotech-tesaro/ 2017-02-10T16:55:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-2016-da-record-ad-ancona-prodotti-oltre-100-mln-di-pezzi/ 2017-02-13T11:42:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-i-vaccini-hanno-trainato-il-2016-attesa-per-shingrix-herpes-zoster/ 2017-02-13T13:21:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/formazione-parte-medtronic-impact-obiettivo-500-mila-discenti-in-5-anni/ 2017-02-13T14:31:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-delude-dengvaxia-ma-la-bu-vaccini-cresce/ 2017-02-13T18:37:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-il-mercato-chiede-un-nuovo-ceo/ 2017-02-13T16:31:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-accordo-tra-biotech-americane-per-candidato-tumore-al-seno/ 2017-02-13T16:48:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-lallarme-dei-ricercatori-avremo-i-farmaci-con-due-anni-di-ritardo/ 2017-02-14T17:41:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibd-accordo-johnson-e-biotech-usa-per-sviluppo-candidati/ 2017-02-14T13:06:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/comunicazione-piattaforma-conferenze-novartis-diventa-canale-tematico/ 2017-02-14T17:47:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-medtronic-amplia-il-portfolio-della-cardiologia-interventistica/ 2017-02-14T15:04:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-pronto-superantibiotico-messo-a-punto-con-finanziamento-pubblico/ 2017-02-14T15:26:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-roche-punta-sulla-combo-herceptin-perjeta/ 2020-11-10T08:32:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-toujeo-sanofi-disponibile-anche-in-italia/ 2017-02-14T16:39:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/top-employers-2017-triplice-riconoscimento-a-msd/ 2017-02-15T12:28:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-cede-asset-per-risanare-il-debito/ 2017-02-15T13:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/artrite-psoriasica-aifa-autorizza-rimborsabilita-di-apremilast-celgene/ 2017-02-15T13:53:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-estetica-allergan-si-rafforza-con-zeltiq/ 2017-02-15T14:15:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-bene-la-monopillola-targata-gsk-johnson/ 2017-02-15T14:30:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mediolanum-farmaceutici-acquisisce-therabel-gienne-pharma/ 2017-02-15T14:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-nuovi-dati-di-efficacia-per-entrectinib-molecola-italiana/ 2017-02-15T16:31:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/verso-il-megamerger-ecco-chi-e-interessato-a-bms/ 2017-02-16T19:16:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neurochirurgia-johnson-johnson-cede-codman/ 2017-02-16T13:52:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-partnership-roche-medtronic-per-sviluppo-glucometro/ 2017-02-16T14:47:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-a-breve-su-mercato-nuovo-sensore-impiantabile-per-glicemia/ 2017-02-20T17:25:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nash-20-milioni-a-startup-biotech-per-studio-candidati/ 2017-02-16T15:12:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-passo-in-avanti-importante-per-doravirina-merck/ 2017-02-16T18:45:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-gilead-cede-candidato-contro-labuso-di-cocaina/ 2017-02-17T11:53:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-a-placche-ok-da-fda-a-siliq-valeant/ 2017-02-17T12:24:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-degli-animali-q4-super-per-zoetis/ 2017-02-17T13:21:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-joint-venture-con-pra-health-anche-in-giappone/ 2017-02-17T13:39:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-illegali-nel-2016-google-ha-bloccato-68-milioni-di-annunci-online/ 2017-02-17T18:46:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-switch-da-infliximab-sicuro-e-costo-efficace/ 2017-02-17T16:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/top-employers-institute-sanofi-italia-prima-nel-settore-farmaceutico/ 2017-02-17T18:17:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-di-chron-funzione-terapia-con-cellule-staminali/ 2017-02-20T12:12:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lynparza-olaparib-efficace-e-sicuro-nel-cancro-al-eno/ 2017-02-20T13:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-ethicon-acquisisce-torax-medical-per-il-segmento-gastrointestinale/ 2017-02-20T13:25:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-ossei-ok-da-fda-per-osteocool-medtronic/ 2017-02-20T16:59:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-vescica-keytruda-merck-allunga-di-3-mesi-la-sopravvivenza/ 2017-02-20T15:55:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/animal-health-da-ema-ok-a-primo-anticorpo-monoclonale-in-eu/ 2017-02-20T17:39:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-ok-da-fda-per-alectinib-in-monoterapia/ 2017-02-21T10:05:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-al-rene-bene-combo-tecentriq-avastin-in-studio-fase-ii/ 2017-02-21T12:10:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-60-anni-di-successi-in-psichiatria/ 2017-02-21T13:38:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-a-revisione-fluorochinoloni-e-chinoloni/ 2017-02-21T13:47:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emofilia-a-acquisita-arriva-in-italia-susoctocog-alfa-shire/ 2017-02-21T14:12:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-la-second-life-di-lynparza-da-fiducia-agli-investitori/ 2017-02-21T16:06:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fibroma-uterino-approvato-in-italia-utilizzo-prolungato-di-esmya-gedeon-richter/ 2017-02-21T16:57:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tutela-della-salute-abbott-e-cittadinanzattiva-firmano-protocollo-dintesa/ 2017-02-22T11:35:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-ecco-le-scadenze-usa-del-2017/ 2017-02-22T12:53:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-luigi-uccella-nuovo-responsabile-hr/ 2017-02-22T15:29:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-tre-nuovi-manager-nel-board-e-carl-ichan-diventa-azionista/ 2017-02-22T15:52:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-buoni-risultati-per-ozanimod-celgene/ 2020-11-10T08:32:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leucemia-speedy-review-fda-per-candidato-pfizer/ 2017-02-22T16:22:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/4869/ 2020-11-10T09:16:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chirurgia-robotica-20-mln-di-dollari-per-sviluppo-pipeline/ 2017-02-23T14:17:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-fatturato-e-previsioni-top-ma-monsanto-preoccupa-gli-analisti/ 2017-02-23T15:26:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-idea-gilead-test-ai-baby-boomers-per-rilanciare-le-vendite/ 2017-02-23T15:39:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutiche-ecco-la-top-ranked-di-fortune/ 2017-02-23T17:47:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-astrazeneca-cede-zoladex-per-mercati-usa-e-canada/ 2017-02-23T17:29:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-big-pharma-vuole-la-riforma-fiscale/ 2017-02-24T14:18:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/classifiche-aziende-per-fast-company-medtronic-e-tra-le-piu-innovative-al-mondo/ 2017-02-24T12:02:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-rene-buoni-risultati-per-la-combo-atezolizumab-bevacizumab-roche/ 2017-02-24T12:30:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-nel-2017-continuera-il-grande-freddo/ 2017-02-24T14:11:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-shire-lancia-la-campagna-social-rare-count/ 2017-02-24T14:32:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saunders-allergan-no-a-valeant-bms-allorizzonte/ 2017-02-24T15:20:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-estetica-con-juvederm-volite-allergan-entra-nella-skin-quality/ 2017-02-27T11:24:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-micromerger-per-espandersi-in-tre-settori/ 2017-02-27T13:41:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-verso-la-trumpcare-ma-non-sara-un-cammino-facile/ 2017-02-27T14:12:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-polmone-chmp-raccomanda-combo-tafinlar-mekinist-novartis/ 2017-02-27T15:02:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-aifa-nuovo-sito-per-segnalazione-eventi-avversi/ 2017-02-27T15:30:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-arriva-nella-ue-natapar-ipoparatiroidismo/ 2017-02-27T15:53:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunosoppressori-chiesi-e-molecular-warehouse-per-monitoraggio-con-smartphone/ 2017-02-28T13:33:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiovascolare-repatha-amgen-rimborsabile-anche-in-italia/ 2017-02-28T15:12:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hcv-mercato-sempre-piu-stretto-scende-valutazione-farmaco-merck/ 2017-02-28T15:46:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-scaccabarozzi-farmindustria-portare-piu-ricerca-in-italia/ 2017-02-28T16:01:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovo-stabilimento-produttivo-in-svizzera-ospite-di-lonza/ 2017-02-28T16:20:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-hcv-marazziti-affari-sociali-si-a-contrattazione-per-paesi-cluster/ 2017-02-28T18:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anemia-di-fanconi-partnership-molmed-biotech-usa-per-sviluppo-terapia-genica/ 2017-02-28T18:05:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-ok-da-fda-a-combo-qtern-astrazeneca/ 2017-03-01T18:27:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/data-privacy-accordo-tra-pke-e-stefanelli-e-stefanelli/ 2017-03-01T18:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-da-fda-priority-review-per-candidato-contro-discinesia-tardiva/ 2017-03-01T15:37:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/4965/ 2017-03-01T18:18:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-ecco-la-lista-dei-batteri-piu-pericolosi/ 2017-03-01T18:39:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-arriva-in-italia-la-prima-terapia-a-base-di-taf-gilead/ 2017-03-01T18:16:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-aumento-prezzi-farmaci-sotto-i-10-punti-allanno-dal-2012/ 2017-03-02T18:26:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-uno-sguardo-sul-marcato-dal-nuovo-vice-president-market-access/ 2017-03-02T18:16:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-olaparib-raggiunge-endpoint-primario-per-cancro-al-seno-metastatico-brca/ 2017-03-02T14:56:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-disco-verde-chmp-per-combo-viekirax-exveira-hcv/ 2017-03-02T15:12:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oftalmologia-fidia-acquisisce-sooft-italia/ 2017-03-02T18:17:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-punta-sulla-digital-health-per-combattere-la-depressione/ 2017-03-02T16:50:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/5004/ 2017-03-02T17:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-studio-aphinity-raggiunge-endpoint-primario-tumore-al-seno/ 2017-03-03T12:02:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-cambio-al-vertice-negli-usa/ 2017-03-03T13:38:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-accordo-usa-ue-per-ispezione-siti-produttivi/ 2017-03-03T13:58:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-sie-accesso-e-iter-piu-rapidi-in-italia/ 2017-03-03T18:12:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-e-arix-insieme-per-sviluppo-progetti-biotech/ 2017-03-03T18:03:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-unapp-per-mettere-a-fuoco-eylea/ 2017-03-03T18:01:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-big-pharma-usa-fa-retromarcia-su-richiesta-trasparenza/ 2017-03-06T13:23:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazenecasanofi-accordo-per-produrre-il-nuovo-vaccino-anti-rsv/ 2017-03-06T15:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-ixekizumab-per-psoriasi-efficace-fino-a-108-settimane/ 2017-03-06T18:14:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-rigenerativa-e-staminali-20-mln-da-provider-sanitari-usa/ 2017-03-06T15:53:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-e-chi-med-antitumorale-centra-obiettivi-fase-3-biotech-cinese-mira-a-impatto-globale/ 2017-03-06T17:51:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herceptin-roche-alta-corte-di-delhi-dice-si-ai-biosimilari-mylan-e-biocon/ 2017-03-07T11:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergopharma-merck-kgaa-nuovo-impianto-in-germania-produrra-allergeni-ricombinanti/ 2017-03-07T11:12:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-la-soluzione-partenrship-con-lindia/ 2017-03-07T17:20:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-giro-daffari-miliardario-entro-il-2022/ 2017-03-07T11:38:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-azionisti-ridurre-lo-stipendio-della-nuova-ceo/ 2017-03-07T13:51:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-arriva-praulent-in-fascia-a/ 2017-03-07T17:49:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncocyte-pronta-al-lancio-test-ematico-per-carcinoma-polmonare/ 2017-03-07T18:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-nice-raccomanda-acido-obeticolico-per-cbp/ 2017-03-08T13:34:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-trump-twitta-e-le-azioni-di-big-pharma-calano/ 2017-03-08T14:04:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-per-il-2022-e-corsa-a-tre-ma-gsk-e-in-testa/ 2017-03-08T14:26:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-definiti-i-nuovi-criteri-di-trattamento-per-lepatite-c/ 2017-03-08T17:02:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-dalla-ricerca-850-farmaci-per-le-donne/ 2017-03-08T17:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-farmaceutica-sempre-piu-donna-e-molte-sono-dirigenti/ 2017-03-08T17:41:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannabis-terapeutica-un-mercato-da-11-mld-di-dollari/ 2017-03-08T17:56:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-su-global-blood-therapeutics-per-rafforzare-lematologia/ 2020-11-10T08:32:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/horizon-discovery-e-amplycell-insieme-per-ricerca-su-linee-cellulari/ 2017-03-09T15:02:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-scommette-ancora-su-gantenerumab-alzheimer/ 2017-03-09T16:05:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-fda-dice-si-a-catetere-per-flutter-atriale/ 2017-03-09T16:32:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-usa-gilead-attacca-i-pbm/ 2017-03-09T16:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-sponsor-maglia-verde-del-giro-ditalia-under-23/ 2017-03-09T18:14:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-pharma-ue-no-al-blanket-prescribing/ 2017-03-10T17:16:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-ceo-doro-richard-gonzalez-abbvie/ 2017-03-10T17:14:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-corsa-a-tre-per-la-presidenza/ 2017-03-10T13:29:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-thomas-lynch-nuovo-responsabile-della-ricerca/ 2017-03-10T15:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aviaria-lfda-cinese-chiede-un-nuovo-vaccino/ 2017-03-10T15:44:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biologici-la-cina-e-sempre-piu-vicina/ 2017-03-10T15:57:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-inaugurate-nuove-sedi-in-bolivia-e-peru/ 2017-03-13T11:30:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biodue-sbarca-oltreconfine-e-joint-venture-con-fufarma-albania/ 2017-03-13T12:36:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/burocrazia-e-tempi-lunghi-fda-cinese-vuole-cambiare-marcia/ 2017-03-13T12:24:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carmelo-lombardo-nuovo-ad-di-zoetis-italia/ 2017-03-13T12:43:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-due-aziende-indiane-esportano-copie-nexavar-e-xarelto-bayer/ 2017-03-13T18:21:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-trump-ha-scelto-gottlieb-per-guidarla/ 2017-03-13T16:01:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ombre-cinesi-sui-generici-tedeschi/ 2017-03-14T17:20:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tigenix-mette-a-punto-prima-terapia-per-linfarto-con-cellule-staminali/ 2017-03-14T11:32:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guerra-brevetti-usa-acorda-vince-causa-per-ampyra-sclerosi-multipla/ 2017-03-14T11:51:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-and-awarness-allergan-lancia-eyeporwement/ 2017-03-14T12:11:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-e-pubblicita-ecco-le-linee-guida-del-ministero-della-salute/ 2017-03-14T20:22:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministero-salute-romano-marabelli-confermato-segretario-generale/ 2017-03-14T14:22:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lynparza-migliora-la-sopravvivenza-nel-carcinoma-ovarico/ 2017-03-15T11:49:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-fondo-di-investimento-lascia-e-crollano-le-azioni-in-borsa/ 2017-03-15T12:52:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-usa-24-mln-di-americani-a-rischio-se-passa-la-trumpcare/ 2017-03-15T13:21:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-bavarian-nordic-efficace-vaccino-contro-ebola/ 2017-03-15T18:32:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-mylan-accordo-per-lancio-biosimilare-herceptin/ 2017-03-15T15:45:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-vende-la-bu-dei-biosimilari/ 2017-03-15T18:38:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eda-accetta-tre-nuove-richieste-per-ertuglifozin-msd-e-pfizer/ 2017-03-16T14:52:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-uk-contestano-politica-dei-prezzi-del-governo-may/ 2017-03-16T15:08:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/keytruda-msd-ok-fda-per-linfoma-hodgkin-refrattario/ 2017-03-16T15:17:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-ex-ceo-di-google-ventures-lancia-fondo-di-investimenti/ 2017-03-16T16:21:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-svizzera-ultimo-step-per-candidato-psoriasi/ 2017-03-16T17:27:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lancia-la-startup-competion-tech-for-health/ 2017-03-16T18:00:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-rischio-carenze-fornitura-e-extracosti-per-il-ssn/ 2017-03-16T18:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cell-medica-fundraising-milionario-per-nuove-terapie-anticancro/ 2017-03-17T11:44:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-meno-fondi-alla-ricerca-oncologica-e-lasco-protesta/ 2017-03-17T12:15:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marathon-acquista-i-diritti-di-emflaza-malattia-di-duchenne/ 2017-03-17T12:56:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/onu-precursori-fentanyl-nella-lista-delle-sostanze-controllate/ 2017-03-17T15:36:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-da-nice-ok-per-cerdelga-nella-dermatite-atopica/ 2017-03-17T17:24:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-con-repatha-rischio-mace-ridotto-del-20-per-cento-studio-fourier/ 2017-03-17T19:05:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-giampaolo-murri-nuovo-market-access-head-oncology/ 2017-03-20T17:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dazi-e-calo-dei-ricavi-le-pharma-indiane-preparano-la-grande-fuga-dagli-usa/ 2017-03-20T17:17:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-per-il-nice-possono-superare-i-600-mila-dollari-a-trattamento/ 2017-03-20T17:25:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-guarda-allasia-per-gli-investimenti/ 2017-03-20T17:34:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayerjohnson-xarelto-batte-aspirina-in-studio-testa-a-testa/ 2017-03-20T18:08:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-studio-italiano-nellanemia-efficaci-come-gli-originator/ 2017-03-20T19:12:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/start-up-ex-manager-gsk-punta-tutto-sulle-infezioni-respiratorie/ 2017-03-21T12:46:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-scommette-su-tecnologia-wireless-per-il-monitoraggio-fetale/ 2017-03-21T13:03:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-social-health-istruzioni-per-luso-in-diretta-streaming/ 2017-03-21T13:45:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-cinese-apre-alloccidente-cambiano-le-regole/ 2017-03-21T14:34:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-acc-futuro-roseo-per-gli-inibitori-sgtl2/ 2017-03-21T15:18:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-presto-in-gu-gli-11-criteri-di-trattamento-per-lepatite-c/ 2017-03-21T18:47:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-eli-lilly-in-cinque-anni-sconti-aumentati-del-50-per-cento/ 2017-03-22T11:16:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-anche-helsinki-tra-le-citta-candidate/ 2017-03-22T13:48:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-vince-causa-in-usa-su-brevetto-tecfidera/ 2017-03-22T14:07:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/deglobalizzazione-nel-pharma-ce-chi-dice-no/ 2017-03-22T14:22:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannabis-in-svizzera-cresce-business-della-depotenziata-ed-e-boom-di-imprenditori/ 2017-03-22T16:43:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-e-i-prezzi-dei-farmaci-un-grande-processo-di-offerta-competitiva/ 2017-03-22T18:59:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/privacy-e-gestione-dei-dati-in-sanita-chi-puo-rilasciare-la-certificazione/ 2017-03-22T19:28:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-accordo-bms-cytom-x-in-biodollari/ 2017-03-23T18:44:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-social-ecco-i-post-con-piu-like-e-i-tweet-piu-seguiti/ 2017-03-23T16:30:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-produrra-bexsero-in-un-ex-stabilimento-novartis/ 2017-03-23T16:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-test-preeclampsia-fara-risparmiare-al-ssn-33-mln-di-euro/ 2017-03-23T17:13:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/serelaxin-novartis-fallisce-endpoint-studio-avanzato/ 2017-03-23T17:50:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-xadago-newron-ok-da-fda-come-terapia-aggiuntiva-nel-parkinson/ 2017-03-23T18:03:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patient-view-2016-al-primo-posto-viiv-healthcare/ 2020-11-10T08:24:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-su-flexion-per-espandersi-nella-biosurgery/ 2017-03-24T11:36:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-regeneron-arruolano-500-mila-britannici-per-studiarne-i-geni/ 2017-03-24T11:53:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-merck-kgaa-in-attesa-dellok-fda-per-bavencio/ 2017-03-24T13:34:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-cura-dimagrante-a-rischio-6-mila-posti-di-lavoro/ 2017-03-24T14:20:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannabis-israele-punta-sul-business-della-terapeutica/ 2017-03-24T15:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fertility-2-award-merck-ecco-i-vincitori/ 2017-03-24T17:04:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-veterinari-ecco-le-nuove-indicazioni-dellema/ 2017-03-24T16:16:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-cardioaspirin-per-la-prevenzione-del-ccr-presentata-domanda-ad-aifa/ 2017-03-27T10:29:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ok-da-chmp-per-refixia-emofilia-b/ 2017-03-27T11:10:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consumer-health-in-italia-nutraceutica-sempre-piu-driver/ 2017-03-27T11:23:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trumpcare-cosa-dice-lamerica-dopo-la-bocciatura/ 2017-03-27T14:31:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-a-task-force-per-analisi-big-data/ 2017-03-27T15:23:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-le-raccomandazioni-ema-per-la-stagione-influenzale-20172018/ 2017-03-27T16:35:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-chmp-a-nivolumab-per-tumore-testa-e-collo/ 2017-03-28T11:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-entresto-farmaco-salvavita-del-business-cardiovascolare/ 2017-03-28T11:16:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dopo-asset-swap-con-bi-nuove-strategie-per-il-consumer/ 2017-03-28T13:09:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gairdner-foundation-2017-premio-a-rino-rappuoli-gsk-vaccines-per-la-reverse-vaccinology/ 2017-03-28T13:09:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prima-fast-track-della-fda-cinese-e-arriva-tagrisso-astrazeneca/ 2017-03-28T13:20:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-medici-senza-frontiere-contro-brevetto-sofosbuvir/ 2017-03-28T13:49:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presidenza-aifa-lorenzin-indica-stefano-vella/ 2017-03-28T14:08:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viagra-otc-pfizer-ci-riprova-e-presenta-richiesta-in-uk/ 2017-03-29T11:32:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-punta-forte-su-lynparza-nei-tumori-femminili/ 2017-03-29T12:23:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-ok-da-fda-per-zejula-tumore-ovarico/ 2017-03-29T14:25:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-fda-approva-dupixent-per-la-dermatite-atopica/ 2017-03-29T16:06:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-vaccino-indiano-contro-il-rotavirus-competera-con-merck-e-gsk/ 2017-03-29T16:22:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-dopo-3-mesi-ok-fda-per-ocrevus-sclerosi-multipla/ 2017-03-29T17:04:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-legittima-limportazione-di-farmaci-se-in-italia-non-sono-accessibili-a-tutti/ 2017-03-29T17:30:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ema-studia-da-fda-per-le-approvazioni-veloci/ 2017-03-30T16:37:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-fda-dice-no-a-generico-advair-gsk/ 2017-03-30T15:17:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-bene-la-combo-kalydecotezacaftor-fibrosi-cistica-si-testa-la-tripla-terapia/ 2017-03-30T15:39:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sospensione-ema-assogenerici-nessun-prodotto-in-vendita-in-italia/ 2017-03-30T17:06:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-sulla-piattaforma-di-warp-drive-bio-per-la-medicina-molecolare/ 2017-03-30T16:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-usa-studia-farmaco-topico-per-neoplasie-cervicali/ 2017-03-30T16:34:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-per-vella-presidente-ce-il-si-della-stato-regioni/ 2017-03-30T18:01:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-terapia-car-t-leucemia-revisione-fast-track-di-fda/ 2017-03-31T11:08:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-usa-uk-accelerano-sui-nuovi-antibiotici/ 2017-03-31T12:12:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anabasum-corbus-efficace-nella-terapia-della-fibrosi-cistica/ 2017-03-31T17:52:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertice-fda-ecco-come-gottlieb-risolvera-il-conflitto-dinteresse/ 2017-03-31T15:42:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/america-first-lilly-investe-850-mln-di-dollari-negli-usa/ 2017-03-31T17:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-governo-sudafricano-insieme-per-la-tb/ 2017-03-31T16:37:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/worldwide-clinical-trials-bill-hirschman-e-il-nuovo-evp/ 2017-04-03T11:10:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-canadese-mette-a-punto-test-per-creme-bioequivalenti-herpes/ 2017-04-03T17:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-venture-5-mln-di-dollari-per-super-colla-batteri/ 2017-04-03T17:12:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vencerx-malattie-neurologiche-rare-ex-pfizer-nuovo-ceo/ 2017-04-03T13:52:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-accordo-con-biotech-per-intelligenza-artificiale-nel-cancro-al-seno/ 2017-04-03T14:32:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-i-criteri-di-rimborsabilita-per-i-daas/ 2017-04-03T16:15:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/combo-tutti-vogliono-incyte-al-via-trial-con-keytruda-msd-e-opdivo-bms/ 2017-04-04T10:47:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-21-giudici-e-due-categorie-premiano-la-comunicazione-pharma/ 2017-04-04T10:55:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-sanofiregeneron-duello-in-corte-dappello-usa-per-repatha/ 2017-04-04T11:06:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-per-tecfidera-nessuna-violazione-brevetto-forward-pharma/ 2017-04-04T13:12:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paratek-antibiotico-omadaciclina-supera-studio-fase-avanzata/ 2017-04-04T15:03:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-quale-politica-di-pricing-per-i-chckpoint-inhibitors/ 2017-04-07T13:24:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-fd-approva-austedo-corea-di-huntington/ 2017-04-05T15:32:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novocure-dispositivo-indossabile-optune-efficace-nel-tumore-del-pancreas/ 2017-04-05T14:55:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-ingheleim-53-mld-di-euro-entro-il-2030-dallanimal-health/ 2017-04-05T15:05:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-blinatumomab-leucemia-rimborsabile-in-italia/ 2017-04-05T18:24:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-ogeda-per-espandersi-nella-ginecologia/ 2017-04-05T16:00:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-johnson-no-da-partner-per-nuovi-studi-su-darzalex/ 2017-04-05T16:15:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-bene-nuove-norme-europee-sui-dm-litalia-ha-fatto-squadra/ 2017-04-05T18:18:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antidepressivi-italia-paese-europeo-che-ne-consuma-di-meno-ma-il-mercato-cresce/ 2017-04-06T17:15:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibm-watson-a-milano-maroni-occasione-da-non-perdere/ 2017-04-06T11:08:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-italia-allu-s-italy-patient-day-2017/ 2020-11-10T08:24:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-sun-pharma-tildrakizumab-sclerosi-a-placche-sul-tavolo-dellema/ 2017-04-06T11:37:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-combo-tafinlar-mekinist-tumore-del-polmone/ 2017-04-06T17:14:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-bill-sibold-a-capo-del-gruppo-in-usa/ 2017-04-06T11:52:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-prepara-lo-sbarco-in-cina-con-ex-vp-roche-alla-guida/ 2017-04-07T10:42:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inovio-combo-vaccino-inibitore-di-checkpoint-per-hiv/ 2017-04-07T11:05:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-autorizza-kit-test-genetici-per-10-patologie/ 2017-04-07T12:58:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-per-inova-il-prezzo-non-e-giusto/ 2017-04-07T16:58:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genomica-unindustria-da-due-mld-di-dollari-con-molte-incognite-etiche/ 2017-04-07T16:59:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-tre-nasce-gsk/ 2017-04-07T16:39:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-fda-estende-sovaldi-e-harvoni-a-popolazione-pediatrica/ 2017-04-10T10:04:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nemico-invisibile-documentario-cnn-sulle-malattie-infettive-sponsor-johnon/ 2017-04-10T10:39:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/svizzera-nasce-vifor-pharma-800-mln-sul-piatto-per-gli-investimenti/ 2017-04-10T10:59:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-parte-sperimentazione-fase-iii-vaccino-dengue/ 2017-04-10T14:31:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-warning-su-clorexidina-a-rischio-un-business-da-56-mld-di-dollari/ 2017-04-10T15:02:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-litalia-riprende-a-inventare-ma-i-numeri-sono-ancora-bassi/ 2017-04-10T15:30:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-lancia-in-europa-proclaim-drg-per-il-dolore-cronico/ 2017-04-10T16:51:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-in-dubbio-su-imetelstat-mielofibrosi-salta-lacquisizione-da-geron/ 2017-04-11T10:19:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-bene-toujeo-nello-studio-real-world/ 2017-04-11T11:11:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-per-fare-cassa-pronta-a-vendere-la-bu-della-salute-femminile/ 2017-04-11T11:22:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merger-q1-fiacco-rispetto-al-2016-spicca-laccordo-johnson-actelion/ 2017-04-11T12:57:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nel-tumore-al-polmone-alecensa-piu-efficace-di-xalkori-pfizer/ 2017-04-11T15:14:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/icer-il-prezzo-di-humira-e-alto-abbvie-verso-una-second-brand-strategy/ 2017-04-11T16:38:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologia-low-cost-azienda-indiana-lancia-test-ematico-per-loncologia/ 2017-04-12T10:40:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/approvazione-farmaci-lfda-e-piu-veloce-dellema/ 2017-04-12T11:03:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neurocrine-fda-approva-ingrezza-discinesia-tardiva/ 2017-04-12T11:25:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-da-fda-lettera-di-richiamo-per-qualita-produzione-in-india/ 2017-04-12T13:04:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-via-a-campagna-sensibilizzazione-su-sclerosi-multipla/ 2017-04-12T14:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-massimo-visentin-nuovo-presidente-gruppo-vaccini/ 2017-04-12T15:07:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-irrompe-nella-bioelettronica-per-la-cura-del-diabete/ 2017-04-13T12:41:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondo-investimenti-usa-punta-40-mln-di-dollari-su-candidato-nash/ 2017-04-13T14:19:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opa-su-startup-usa-il-portfolio-fa-gola-a-takeda-e-lundbeck/ 2017-04-13T14:40:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-va-alle-terme-distribuira-lacqua-di-sirmione/ 2017-04-13T14:48:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-usa-accusa-istituto-ramazzini-la-replica-seguiti-gli-standard-internazionali/ 2017-04-14T13:58:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xenotrapianti-business-del-futuro/ 2017-04-13T16:07:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-enzo-moavero-ambasciatore-del-governo-italiano/ 2017-04-14T13:28:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fda-estende-tecentriq-a-tumore-vescica-come-trattamento-prima-linea/ 2017-04-18T10:23:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncomed-tarextumab-tumore-al-polmone-fallisce-studio-fase-intermedia/ 2017-04-18T13:16:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-alere-diagnostici-e-sua-dopo-un-anno-di-trattative-e-colpi-di-scena/ 2017-04-18T14:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-incyte-fda-dice-no-a-olumian-artrite-reumatoide/ 2017-04-18T17:30:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/buoni-risultati-per-emicizumab-roche-nuovo-competitor-nellemofilia/ 2017-04-18T16:34:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-e-nash-novartis-spinge-sullacceleratore/ 2017-04-18T16:10:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/non-compliance-terapeutica-il-killer-silenzioso-degli-usa/ 2017-04-19T17:16:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-i-lysibodies-sono-la-soluzione/ 2017-04-19T10:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shopping-cardinal-health-tre-bu-medtronic-per-ampliare-il-business-dei-dispositivi/ 2017-04-19T17:16:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q1-sotto-le-aspettative-ma-con-actelion-previsioni-ottimistiche/ 2017-04-19T14:25:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-entro-due-anni-formulazione-pediatrica-di-praziquantel-schistosomiasi/ 2017-04-19T17:34:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-antibiotici-iclaprim-motif-bio-efficace-come-vancomicina/ 2017-04-19T14:57:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-un-mercato-da-300-mld-di-dollari/ 2017-04-20T13:42:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-2016-da-incorniciare/ 2017-04-20T13:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricciardi-iss-in-italia-ce-unepidemia-di-morbillo/ 2017-04-20T17:36:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-evidenze-positive-per-emicizumab-emofilia/ 2017-04-20T14:40:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/credit-suisse-laumento-dei-prezzi-fa-crescere-gli-utili-ma-non-per-tutti/ 2017-04-20T17:51:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-aringhieri-progetto-giovani-per-avvicinare-gli-studenti-alla-ricerca/ 2017-04-20T17:20:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-svizzera-testa-a-testa-per-un-mercato-da-800-mln-di-dollari/ 2017-04-21T16:12:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-sfida-gsk-nel-respiratorio-e-lancia-generico-di-advair/ 2017-04-21T13:11:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-veliparib-fallisce-due-late-stage-trial/ 2017-04-21T13:24:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fujifilm-dalle-foto-ai-farmaci-biologici-con-130-mln-di-dollari/ 2017-04-21T17:08:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-ecco-la-top-five-dei-farmaci-piu-costosi/ 2017-04-21T16:59:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-gates-300-mln-di-dollari-per-sconfiggere-le-malattie-tropicali/ 2017-04-21T15:53:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uniqure-ritira-prima-terapia-genica-approvata-in-europa/ 2017-04-26T15:44:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofiregeneron-panel-ema-raccomanda-approvazione-kevzara-artrite-reumatoide/ 2017-04-26T15:44:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bigpharma-punta-sulla-steatoepatite-non-alcoolica/ 2020-11-10T19:27:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-co-dopo-crollo-novembre-azioni-si-impennato-del-22/ 2017-04-26T15:00:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malaria-oms-al-via-sperimentazione-sul-campo-primo-vaccino-approvato/ 2017-04-26T15:07:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-si-accaparra-akorn-e-lunita-biosimilari-di-merck-kgaa/ 2017-04-26T15:45:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/portfolio-otc-per-johnson-novartis-e-takeda-e-in-brasile/ 2017-04-27T13:16:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-amgen-insieme-per-erenumab-emicrania/ 2017-04-27T15:33:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-il-q1-chi-spingera-le-vendite-dopo-enbrel/ 2017-04-27T16:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-ssn-innovativo-ed-equo-nhs-a-rischio-collasso/ 2017-04-27T16:16:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-pharma-teme-per-uk-un-tiny-market/ 2017-04-27T16:59:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gentiloni-milano-ha-ottime-chance-per-nuova-sede-ema/ 2017-04-27T17:11:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epatite-c-aifa-autorizza-rimborsabilita-epclusa-gilead/ 2017-04-27T17:48:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-135-mln-di-dollari-per-produrre-adc/ 2017-04-28T15:42:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/world-economic-forum-piattaforma-multistakeholder-per-valutare-farmaci/ 2017-04-28T16:09:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-da-fda-ok-a-farmaco-per-malattia-rara-ma-il-prezzo-e-altissimo/ 2017-04-28T16:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ancora-leader-nella-sm-ma-aumenta-la-concorrenza/ 2017-04-28T16:24:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-da-fda-per-stivarga-cancro-epatico/ 2017-04-28T16:36:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-parere-positivo-chmp-per-besponsa-leucemia-linfoblastica-acuta/ 2017-04-28T16:52:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-si-della-fda-a-imfinzi-tumore-vescica/ 2020-11-10T08:32:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-dopo-acquisto-ariad-fda-approva-alunbrig-tumore-al-polmone/ 2017-05-02T12:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-doppia-indicazione-per-rydapt-leucemia-mieloide-acuta/ 2017-05-02T12:55:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-italia-jean-yves-chatelan-nuovo-vice-presidente-e-general-manager/ 2017-05-02T13:30:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/india-stretta-sui-prezzi-dei-md-big-pharma-a-rischio-gli-investimenti/ 2017-05-02T16:09:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-spinge-belysta-139-milioni-di-dollari-in-linee-produttive/ 2017-05-02T16:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-sotto-le-aspettative-read-ancora-presto-per-nuovi-accordi/ 2017-05-03T18:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-ce-approva-varuby-rolapitant-per-nausea-da-chemioterapia/ 2017-05-03T17:33:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-vaccini-a-gonfie-vele-nel-q1/ 2017-05-03T18:00:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q1-poco-felice-ma-cash-robusto-per-acquisizioni/ 2017-05-03T16:17:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/30-marzo-2019-fuga-da-londra-ema-suddivide-il-lavoro-fra-le-agenzie-nazionali/ 2017-05-03T18:05:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-alessandra-aloe-consigliere-della-ssfa/ 2017-05-03T17:06:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-investe-ancora-nei-checkpoint-inhibitors/ 2017-05-04T15:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-punta-forte-sullasma-partnership-con-biotech-da-2-mld-di-dollari/ 2017-05-04T17:48:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neurotrope-il-mercato-non-crede-al-candidato-per-lalzheimer/ 2017-05-04T16:01:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-sala-ci-crede/ 2017-05-04T17:50:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-johnson-vincono-prima-causa-usa-per-xarelto/ 2017-05-04T17:45:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sunesis-dopo-fda-anche-da-ema-boccia-vosaroxin-alzheimer/ 2017-05-04T17:22:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cresce-la-spesa-farmaceutica-ma-il-tasso-e-sotto-il-5-per-cento/ 2017-05-05T11:12:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-xtandi-delude-nel-q1/ 2017-05-05T11:50:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-cambia-strategia-alessandro-riva-in-cabina-di-regia/ 2017-05-05T16:12:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-da-fda-per-durvalumab-carcinoma-uroteliale/ 2017-05-05T12:54:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-stop-agli-abusi-sui-bambini-il-progetto-contro-la-pedofilia/ 2017-05-05T14:33:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-disegna-la-farmacia-4-0/ 2017-05-05T15:16:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riesplode-farmacopoli/ 2017-05-08T18:22:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-ibg-bene-guida-ema-ue/ 2017-05-08T17:29:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mitsubishi-arriva-lok-fda-a-edavarone-sla/ 2017-05-08T16:56:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-usa-dove-lexecutive-chairman-guadagna-piu-del-ceo/ 2017-05-08T11:28:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-bene-relvar-in-nuovo-studio-real-world/ 2017-05-08T15:39:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-ad-amesterdam-si-parla-di-fair-pricing/ 2017-05-08T16:08:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-modello-ebola-per-la-profilassi-del-futuro/ 2017-05-08T16:49:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-novartis-investono-su-biotech-vivet-malattie-rare/ 2017-05-09T10:49:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-200-mln-di-euro-per-ampliare-produzione-biologici/ 2017-05-09T12:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptc-therapeutics-abbassa-il-prezzo-di-emflaza-distrofia-di-duchenne/ 2017-05-09T14:32:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-per-keytruda-pembrolizumab-ce-lok-della-commissione-europea/ 2017-05-09T15:00:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-nasce-comitato-tecnico-ue-per-i-prezzi/ 2017-05-09T16:10:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-studio-clinico-riaccende-la-polemica-su-epipen/ 2017-05-09T16:33:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-delusione-e-sconcerto-per-gli-esiti-dellindagine-di-parma/ 2017-05-09T17:34:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-saunders-ribadisce-niente-megafusioni/ 2017-05-10T12:17:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merck-kgaa-ok-per-bavencio-anche-nel-cancro-alla-vescica/ 2017-05-10T17:15:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-inaugurata-scuola-a-norcia-con-fondazione-francesca-rava/ 2017-05-10T14:14:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-in-usa-aumento-prezzi-farmaci-sotto-il-5-per-cento/ 2017-05-10T14:30:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-nuovo-acquisto-di-biotech-nellarea-oncologica/ 2017-05-10T16:09:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-milano-linternational-forum-on-cancer-patients-empowerment/ 2020-11-10T08:24:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-q1-sotto-le-stime-ma-fiducia-nel-mercato/ 2017-05-11T16:24:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-alza-la-voce-contro-fda-che-non-approva-generico-di-advair/ 2017-05-11T17:25:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salix-guarda-ai-gp-con-uno-strumento-per-viaggiare-nellintestino/ 2017-05-11T17:35:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-maggiore-omogeneita-internazionale-nelle-politiche-per-i-vaccini/ 2017-05-11T17:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lancia-in-i-italia-il-primo-device-elettronico-per-lasma/ 2017-05-11T18:13:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-accordo-con-sangamo-per-candidati-terapia-genica-emofilia/ 2017-05-11T18:13:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-e-accessibilita-farmaci-richiamo-delloms-il-problema-e-globale-ci-vuole-trasparenza/ 2017-05-12T11:38:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-punta-sullobesita-per-curare-il-diabete/ 2017-05-12T15:25:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-disco-verde-fda-per-combo-keytruda-chemioterapia/ 2017-05-12T15:25:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-con-nuove-regole-in-manovra-meno-contenziosi-con-aziende/ 2017-05-12T15:18:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nel-2016-raccomandati-27-nuovi-principi-attivi/ 2017-05-12T15:33:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-per-il-chairman-weinberg-nessun-bisogno-di-acquisizioni/ 2017-05-12T16:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-accordo-con-cro-per-accesso-in-europa-a-zejula-tumore-ovaio/ 2017-05-15T16:29:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pronte-3000-mila-dosi-di-vaccino-contro-ebola/ 2017-05-15T16:18:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-da-oggi-epclusa-disponibile-in-italia/ 2017-05-15T15:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hra-pharma-italia-james-mac-donald-nuovo-general-manager/ 2017-05-15T16:14:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-bene-il-trial-su-galcanezumab-emicrania/ 2017-05-15T13:32:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-durvalumab-il-golden-bullet-delloncologia/ 2017-05-15T14:37:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-riprende-fiato-con-provenge-carcinoma-alla-prostata-ok-studio-real-world/ 2017-05-16T11:55:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quintilesims-in-italia-aumenta-la-spesa-per-gli-antistaminici-campania-al-primo-posto/ 2017-05-16T12:31:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-cinese-sempre-piu-occidentale-arrivano-le-concessioni-condizionate/ 2017-05-16T14:35:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-gsk-il-cash-per-il-big-takeover-con-astrazeneca/ 2017-05-16T15:12:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-acquista-patheon-obiettivo-la-filiera-del-laboratorio/ 2017-05-16T16:11:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aspen-sotto-i-riflettori-dellantitrust-europea/ 2017-05-16T16:30:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-alfonso-gentile-nuovo-medical-e-regulatory-director/ 2017-05-17T12:12:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-delegazione-agenzia-a-milano-per-esame-candidatura/ 2017-05-17T17:42:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-in-usa-vincono-i-generici-teva-mylan-e-novartis-sul-podio-2016/ 2017-05-17T13:02:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-sop-consiglio-di-stato-si-a-pubblicita/ 2017-05-17T13:24:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-chiede-a-johnson-nuovo-warning-su-invokana-canaglifozin/ 2017-05-17T13:41:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-da-fda-priority-review-per-copanlisib-linfoma/ 2017-05-17T16:17:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/monsanto-da-ce-ok-per-10-anni-a-glifosfato/ 2017-05-18T15:02:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-punta-tutto-sui-biologici/ 2017-05-18T15:16:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-pianeta-giovani-sanofi-per-gli-sport-invernali/ 2017-05-18T15:30:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/meridian-i-test-per-il-piombo-nel-sangue-non-funzionano-allarme-fda/ 2017-05-18T15:49:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-india-5-anni-per-rientrare-negli-standard-internazionali/ 2017-05-18T16:29:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-al-via-campagna-di-informazione-sui-nuovi-dm/ 2017-05-18T17:13:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-buoni-risultati-da-talazoparib-tumore-al-seno/ 2017-05-19T10:53:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-allunga-la-sopravvivenza-nel-tumore-alla-vescica/ 2017-05-19T11:07:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-enasidenib-migliora-la-sopravvivenza-nella-leucemia-mieloide-acuta/ 2017-05-19T15:49:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunogen-candidato-tumore-ovaio-anche-in-combo-con-keytruda-msd-e-avastin-roche/ 2017-05-19T13:52:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-pronta-a-chiedere-lok-a-fda-per-lanadelumab-angoioedema-ereditario/ 2017-05-19T14:48:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/6058/ 2017-05-19T14:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-pembrolizumab-keytruda-rimborsabile-per-carcinoma-polmonare-in-prima-e-seconda-linea/ 2017-05-19T15:38:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-gardasil-utile-anche-contro-tumori-testa-e-collo/ 2017-05-22T12:44:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-da-chpm-per-zydakia-tumore-al-polmone/ 2017-05-22T17:26:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-iterum-sperimentera-il-suo-antibiotico-sulopenem-infezioni-urinarie/ 2017-05-22T14:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-il-grande-mercato-delle-malattie-rare/ 2017-05-22T15:01:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-incyte-funziona-la-combo-keytruda-epacadostat/ 2017-05-22T15:28:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-dallasia-un-mld-di-fatturato-entro-il-2021/ 2017-05-22T16:26:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tante-speranze-per-benralizumab-asma/ 2017-05-23T12:42:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-fda-approva-sarilumab-artrite-reumatoide/ 2017-05-23T18:06:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/g20-della-salute-i-ministri-verso-obbligatorieta-prescrizione-antibiotici/ 2017-05-23T13:14:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-si-espande-in-america-latina-continente-dellobesita/ 2017-05-23T17:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-accordo-con-astrazeneca-per-i-diritti-europei-di-due-farmaci/ 2017-05-23T17:15:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-biotechnology-da-fda-si-con-riserva-per-neratinib-cancro-al-seno/ 2017-05-23T17:25:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-ok-da-chmp-a-oxervate-cheratite-neurotrofica/ 2017-05-24T12:39:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-uk-un-settore-leader-che-la-brexit-potrebbe-spazzare-via/ 2017-05-24T14:22:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approvazione-keytruda-msd-caso-scuola/ 2017-05-24T15:51:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/offrire-servizi-tramite-canali-digitali/ 2017-05-24T17:07:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lapproccio-multicanale-abbraccia-sia-linnovazione-che-il-tradizionale/ 2017-05-24T17:07:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-digitale-puo-rivoluzionare-il-modo-in-cui-le-cure-arrivano-alle-persone/ 2017-05-24T17:10:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-sfida-ingaggiare-i-nostri-interlocutori-anche-online/ 2017-05-24T17:10:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-significa-innovazione-e-sostenibilita-del-modello-di-business/ 2017-05-24T17:08:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/essere-omnichannel-per-comunicare-in-modo-giusto/ 2017-05-25T16:41:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-significa-cambiamento-culturale-e-investimento-a-tutti-i-livelli/ 2017-05-24T17:09:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-engagement-linea-comune-per-pazienti-e-medici/ 2017-05-24T16:20:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gw-pharmaceuticals-presto-richiesta-alla-fda-per-epidiolex-epilessia/ 2017-05-25T15:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-da-chmp-per-biosimilare-insulina-lispro/ 2017-05-25T16:31:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ucb-dubbi-su-sicurezza-cardiovascolare-di-romosuzumab-osteoporosi/ 2017-05-25T16:57:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-msd-associazioni-pazienti-a-scuola-di-fundraising/ 2020-11-10T09:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/transmedics-ok-fda-a-primo-device-per-trasporto-organi/ 2017-05-26T11:08:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-farmaci-gia-63-approvazioni-nel-2017-fra-fda-ed-ema/ 2017-05-29T11:20:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitrust-uk-accusa-merck-di-concorrenza-sleale-lazienda-abbiamo-rispettato-le-regole/ 2017-05-30T14:40:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/21st-century-oncology-per-evitare-il-fallimento-si-spera-nei-fondi-dinvestimento/ 2017-05-26T15:07:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/approvazioni-fast-track-cosa-accade-dopo-la-messa-in-commercio-dei-farmaci/ 2017-05-26T15:58:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-pharma-priority-review-fda-per-la-sua-terapia-car-t/ 2017-05-29T10:25:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-boeringher-ingelheim-testa-a-testa-nella-fibrosi-polmonare/ 2017-05-29T15:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-gonzalez-ceo-grazie-ai-flussi-di-cassa-cresceremo-in-tutti-i-settori/ 2017-05-29T16:15:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-sponsor-di-un-talent-show-su-youtube/ 2017-05-29T16:37:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-panel-fda-ok-a-biosimilare-epogen-e-procrit/ 2017-05-29T17:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brazil-intermedica-lancia-unipo/ 2017-05-29T17:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-sempre-piu-a-rischio-hacker/ 2017-05-30T13:06:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-bene-fase-iii-candidato-sclerosi-multipla/ 2017-05-30T16:41:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-vita-per-curosourf-chiesi/ 2017-05-30T17:03:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-positive-evidenze-per-pirfenidone-fibrosi-polmonare-idiopatica/ 2017-05-30T17:02:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-il-vaccino-contro-ebola-usato-in-congo-contro-epidemia/ 2017-05-30T17:09:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-funziona-la-combo-con-bictegravir-hi/ 2017-05-30T17:30:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-chiede-a-fda-estensione-indicazioni-tresiba-diabete/ 2017-05-31T12:37:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-da-fda-per-zykadia-come-trattamento-di-prima-linea-del-tumore-al-polmone/ 2017-05-31T12:50:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jimenez-ceo-novartis-puntiamo-a-fusioni-tra-i-due-e-i-cinque-mld-di-dollari/ 2017-05-31T19:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-in-usa-brilinta-e-bydureon-valutati-pay-for-performance/ 2017-05-31T14:01:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ce-approva-vaccino-trumemba-menb/ 2017-05-31T16:18:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-ema-dice-si-a-biosimilari-di-humira-abbvie-e-remicade-janssen/ 2017-05-31T17:14:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apotex-teva-aurobindo-e-glenmark-in-quattro-per-strattera-eli-lilly/ 2017-06-01T17:26:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inthera-bioscience-9-mln-di-euro-da-merck-ventures-per-candidato-hpv/ 2017-06-01T16:26:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-bene-late-stage-studio-su-fremanezumab-cefalea/ 2017-06-01T16:43:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-governo-usa-epipen-pagato-il-triplo/ 2017-06-01T16:53:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/start-up-di-illumina-si-fonde-con-gemella-di-hong-kong-ed-entra-nei-mercati-asiatici/ 2017-06-01T17:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-da-ce-via-libera-a-nusinersen-atrofia-muscolare-spinale/ 2017-06-01T17:09:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-nessuna-correlazione-tra-vaccini-e-morti/ 2017-06-01T17:29:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-buoni-risultati-per-cyramza-nel-tumore-alla-vescica-presto-lestensione/ 2017-06-05T15:11:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lynparza-tumore-al-seno-efficace-nel-triplo-negativo/ 2017-06-05T15:24:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-zyrtiga-tumore-alla-prostata-riduce-rischio-di-morte-rimane-problema-prezzo/ 2017-06-05T17:32:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-al-via-collaborazione-con-ibm-watson/ 2017-06-05T18:10:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-aelctinib-tumore-al-polmone-dimezza-rischio-progressione-malattia/ 2017-06-05T16:58:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-mike-pence-smantellare-la-legge-entro-lestate/ 2017-06-05T17:30:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-italia-paese-pro-innovation/ 2017-06-06T10:04:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-e-juno-lo-stato-dellarte-delle-terapie-car-t/ 2017-06-06T11:22:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dendreon-asco-nuovi-dati-su-vaccino-contro-cancro-alla-prostata/ 2017-06-06T11:29:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-oncology-punta-forte-su-alunbrig-alk-inibitore/ 2017-06-06T13:16:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-most-reputable-pharma-company-la-classifica-del-reputation-institute/ 2017-06-06T13:47:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-le-novita-su-emodialisi-e-dialisi-peritoneale-al-congresso-di-madrid/ 2017-06-06T14:11:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lung-therapeutics-27-mln-di-dollari-per-sviluppare-candidati-enfisema-e-fibrosi-polmonare/ 2017-06-07T11:26:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-mette-in-vendita-bausch-lomb-allergan-alla-porta/ 2017-06-07T12:38:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/edwards-lifesciences-ok-da-fda-a-sapien-3-valve-in-valve/ 2017-06-07T14:18:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loxo-ottimi-risultati-per-candidato-anticancro-multitasking/ 2017-06-07T13:15:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nanjing-biotech-la-via-cinese-alla-terapia-car-t/ 2017-06-07T16:42:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cede-zomig-emicrania-a-grunenthal/ 2017-06-07T16:08:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-obamacare-e-in-una-spirale-di-morte/ 2017-06-08T13:52:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/universita-ecco-le-10-piu-tecnologiche-dellasia-pacifica/ 2017-06-08T16:51:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-allasco-hanno-vinto-le-terapie-car-t/ 2017-06-08T17:06:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disclosure-code-germania-il-paese-piu-trasparente/ 2017-06-08T15:54:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-ecco-una-app-per-pazienti-con-alzheimer/ 2017-06-08T16:06:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-al-vertice-dellimmuno-oncologia-gli-analisti-ci-credono/ 2017-06-08T17:55:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-55-mln-di-dollari-per-candidato-antidiabetico/ 2017-06-09T10:59:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lantus-antidiabetico-best-seller-2016-in-usa/ 2017-06-11T14:48:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sfida-a-tre-per-il-tumore-al-polmone/ 2017-06-11T14:57:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nasce-bi-x-per-le-soluzioni-digitali/ 2017-06-11T15:03:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/healthcare-provider-cinese-lancia-ipo-per-la-borsa-di-hong-kong/ 2017-06-11T15:23:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/actelion-uno-studio-promuove-cadazolid-antibiotico-laltro-lo-boccia/ 2017-06-11T15:36:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giappone-i-farmaci-generici-non-decollano-e-il-governo-non-taglia-i-prezzi/ 2017-06-12T09:56:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kleo-pharma-douglas-manion-e-il-nuovo-ceo/ 2017-06-12T12:18:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-eli-lilly-jardiance-diabete-riduce-del-38-il-rischio-di-morte-ma-non-si-sa-perche/ 2017-06-12T12:24:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malaria-parte-sperimentazione-nuovo-vaccino/ 2017-06-12T13:02:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-loxo-errore-genetico-nuova-strada-per-gli-antitumorali/ 2017-06-12T14:01:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-grandi-manovre-ai-vertici-dellinnovazione/ 2017-06-12T16:51:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-cambio-al-vertice-dahinden-nuovo-ad/ 2017-06-13T08:52:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-invokana-diabete-riduce-mortalita-cardiovascolare/ 2017-06-13T10:05:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ceo-schwan-perjeta-tumore-al-seno-farmaco-del-futuro/ 2017-06-13T10:42:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/coherus-fda-boccia-biosimilare-di-neulasta-amgen/ 2017-06-13T11:06:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/addio-a-mario-veronesi-porto-la-dialisi-in-europa/ 2017-06-13T12:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-johnson-vincono-seconda-causa-usa-su-xarelto/ 2017-06-13T13:28:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-valentino-confalone-e-il-nuovo-general-manager/ 2017-06-14T10:37:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nuova-sede-il-consiglio-europeo-vota-le-linee-guida/ 2017-06-14T16:55:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ema-pdma-database-condiviso-per-sviluppare-nuovi-antibiotici/ 2017-06-14T10:55:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-bene-galcanezumab-emicrania-presto-alla-fda/ 2017-06-14T13:40:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studi-adattativi-il-futuro-della-ricerca-clinica/ 2017-06-14T16:57:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-importexport-italia-2016-saldo-negativo-di-300-mln/ 2017-06-14T15:58:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nas-adelmo-lusi-nuovo-comandante-il-saluto-del-ministro-lorenzin/ 2017-06-15T17:35:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-ingelheim-italia-sabine-greulich-nominata-presidente/ 2020-11-10T08:51:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-punta-forte-sui-biologici-600-mln-di-euro-nei-prossimi-2-anni/ 2017-06-15T15:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chi-med-passo-avanti-per-fruquintinib-milestone-payment-da-eli-lilly/ 2017-06-15T15:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-bene-pimodivir-influenza-ora-late-stage-trial/ 2017-06-15T16:36:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotime-renevia-centra-lendpoint-dello-studio-si-apre-il-mercato-della-chirurgia-estetica/ 2017-06-15T17:39:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adamis-arriva-negli-usa-symjepi-competitor-di-epipen-mylan/ 2017-06-16T15:02:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-scommette-su-biotech-in-europa-fondo-da-300-mln-di-dollari/ 2017-06-16T15:14:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-in-uk-ministero-salute-rende-disponibile-kadcycla-tumore-al-seno/ 2017-06-16T15:28:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/redhill-bekinda-gastroenterite-raggiunge-lobiettivo-ora-domanda-alla-fda/ 2017-06-16T15:54:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/review-della-letteratura-e-lora-dellintelligenza-artificiale/ 2017-06-16T16:12:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-camilla-borghese-khevenhuller-ibi-lorenzini-la-mela-doro-premio-bellisario/ 2017-06-16T16:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-corte-suprema-usa-no-al-limite-dei-sei-mesi/ 2017-06-19T18:04:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/braun-e-philips-accordo-pluriennale-per-lanestesia-locoregionale/ 2017-06-19T12:21:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-actelion-nasce-idorsia/ 2017-06-19T12:37:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-parexel-wearable-technology-per-gli-studi-clinici/ 2017-06-19T16:17:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-punta-tutto-sui-biologici-ad-azienda-coreana-il-sito-produttivo-irlandese/ 2017-06-19T16:27:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-da-ce-ok-a-rixathon-rituximab-biosimilare/ 2017-06-19T17:26:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-novartis-derby-svizzero-per-i-biosimilari-in-europa/ 2017-06-20T11:07:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melinta-usa-ok-da-fda-a-nuovo-antibiotico-per-infezioni-aucte-della-pelle/ 2017-06-20T17:15:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amcham-italia-strategica-per-il-medical-device-nasce-gruppo-di-lavoro/ 2017-06-20T12:43:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-ottimi-risultati-per-rubraca-tumore-al-seno-presto-estensione-indicazioni/ 2017-06-20T18:08:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-storico-sorpasso-in-europa-sui-branded/ 2017-06-20T16:36:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gamida-cell-40-milioni-per-studio-su-nicord-amlopidina-novartis-tra-i-finanziatori/ 2017-06-20T17:01:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evaluatepharma-vendite-farmaci-in-calo-dopo-dieci-anni/ 2017-06-21T11:31:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-fumata-nera-sulla-scelta-dei-criteri/ 2017-06-21T16:11:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-con-epclusa-epatite-c-passo-avanti-verso-leradicazione/ 2017-06-21T16:10:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-e-aiom-premio-per-il-miglior-progetto-su-tumori-testa-collo/ 2017-06-21T16:23:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-per-lynparza-un-futuro-nel-trattmento-del-tumore-della-prostata/ 2017-06-21T16:53:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seattle-genetics-stop-a-studio-late-stage-su-candidato-aml/ 2017-06-21T16:52:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-da-fda-ok-per-mydayis-adhd/ 2017-06-22T16:12:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-warning-fda-non-ostacolare-larrivo-sul-mercato/ 2017-06-22T16:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vineti-usa-lancia-piattaforma-accesso-alle-terapie-car-t/ 2017-06-22T16:47:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quintiles-ims-vende-il-ramo-sales-business/ 2017-06-22T17:07:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-azionisti-insoddisfatti-ma-la-crescita-e-a-due-cifre/ 2017-06-22T17:23:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-galeno-ecco-i-magnifici-cinque/ 2017-06-22T17:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-acquisisce-electrical-geodesic-e-amplia-il-portfolio-del-mapping-cerebrale/ 2017-06-23T15:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-evidenze-per-ocrelizumab-sclerosi-multipla/ 2017-06-23T15:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-un-anno-dopo-asse-franco-tedesco-per-sedi-ema-ed-eba/ 2017-06-23T16:14:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-serve-unaifa-piu-elastica/ 2017-06-23T16:23:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-candidato-degenerazione-maculare-superiore-in-studio-testa-a-testa/ 2017-06-23T16:41:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fda-approva-nuova-formulazione-di-rituximab/ 2017-06-23T17:16:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-via-libera-in-europa-a-mavenclad-sclerosi-multipla/ 2017-06-27T09:41:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-semaglutide-fa-dimagrire-molto-si-punta-la-mercato-dellobesita/ 2017-06-26T12:08:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-disco-verde-dal-chmp-per-il-biosimilare-imraldi-ma-il-mercato-crede-ancora-in-humire-abbvie/ 2017-06-26T17:18:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-sempre-piu-evidenze-per-kisqali-cancro-al-seno/ 2017-06-26T16:09:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-shingrix-herpes-zoster-centra-obiettivi-fase-iii/ 2017-06-26T16:38:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trumpcare-il-primo-step-e-lok-al-budget-2018-per-la-sanita/ 2017-06-26T17:31:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lions-health-2017-tra-innovazione-reputation-e-trasparenza/ 2017-06-27T15:01:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-ue-avvia-prima-indagine/ 2017-06-27T15:36:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-vola-ma-monsanto-continua-a-preoccupare-gli-analisti/ 2017-06-27T15:57:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-si-dal-chmp-per-triplice-terapia-hcv-in-ununica-compressa/ 2017-06-27T16:20:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seattle-genetics-e-takeda-adcetris-linfoma-hodgkin-centra-obiettivo-studio-late-stage/ 2017-06-27T17:16:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-commissione-europea-approva-erelzi-etanercept-biosimilare/ 2017-06-27T17:18:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-dal-chmp-per-maviret-hcv/ 2017-06-28T15:04:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fisher-ok-da-fda-per-test-biomarker-di-tre-terapie-contro-cancro-al-polmone/ 2017-06-28T15:23:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-gia-23-i-farmaci-approvati-nel-2017-ecco-la-top-ten/ 2017-06-28T17:02:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-ce-approva-sarulimab-artrite-reumatoide/ 2017-06-28T17:30:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-fondo-olandese-15-investimenti-nel-biotech-europeo/ 2017-06-28T16:42:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-si-da-chmp-a-regorafenib-trattamento-di-seconda-linea-dellepatocarcinoma/ 2017-06-28T17:20:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-nuovo-cda-entra-eric-cornut/ 2017-06-30T09:53:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-acquisisce-spectranetics-corporation-nasce-colosso-del-vascolare/ 2017-06-30T10:16:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iapg-fabrizio-greco-abbvie-nuovo-presidente/ 2017-06-30T10:25:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-sanitaria-usa-gorsky-johnson-necessari-10-o-20-anni/ 2017-06-30T14:58:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quintiles-ims-porta-le-pharma-nel-cloud/ 2017-07-02T18:52:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-janssen-italia-il-premio-le-fonti-2017/ 2017-06-30T15:32:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-via-libera-da-ce-per-besponsa-leucemia/ 2017-07-03T08:46:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-accelera-abrogare-subito-obamacare-poi-nuova-legge/ 2017-07-03T09:24:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-arriva-in-italia-ixekizumab-psoriasi-a-placche/ 2017-07-03T09:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-consigli-per-gli-acquisti-in-prima-fila-ce-vertex/ 2017-07-03T14:50:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-2022-evaluate-pharma-msd-scala-posizioni/ 2017-07-03T15:22:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-acquisisce-mysugr-per-espandersi-nel-controllo-integrato-del-diabete/ 2017-07-03T15:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-acquisiti-da-astrazeneca-i-diritti-ue-di-metroprololo/ 2017-07-04T09:46:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-quintilesims-italia-bene-la-convenzionata-in-rosso-lospedaliera/ 2017-07-04T16:51:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-e-crt-nuove-molecole-da-portare-in-sperimentazione/ 2017-07-04T14:26:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-un-anno-dopo-baxalta-le-sfide-e-il-mercato/ 2017-07-05T08:10:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-e-lera-dellintelligenza-artificiale/ 2017-07-04T16:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-da-tigenix-produzione-europea-di-candidato-malattia-di-chron/ 2017-07-04T16:08:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-grant-for-fertility-innovation-piu-di-1-milione-di-euro-alla-ricerca-per-la-fertilita/ 2017-07-05T15:51:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-corte-suprema-del-canada-pone-fine-alla-promise-doctrine/ 2017-07-05T17:35:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depuy-synthes-acquisisce-sentio-e-amplia-portfolio-chirurgia-spinale/ 2017-07-05T16:14:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-off-patent-e-senza-competitor-fda-pubblica-elenco/ 2017-07-05T18:03:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-per-mirogabalin-dolore-luci-e-ombre-nei-trial/ 2017-07-05T17:00:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angle-uk-test-ematico-parsortix-identifica-cancro-ovarico-nel-95-per-cento-dei-casi/ 2017-07-05T17:09:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-team-swat-per-evadere-richieste-farmaci-malattie-rare/ 2017-07-06T16:34:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-governo-inglese-collaboriamo-con-lema/ 2017-07-06T16:41:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-33-milioni-di-sterline-per-lintelligenza-artificiale-di-exscientia/ 2017-07-06T16:52:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/araclon-sperimentazione-vaccino-alzheimer-su-piattaforma-ixico/ 2017-07-06T17:08:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-chmp-approva-aggiornamento-indicazioni-di-cosentyx/ 2017-07-06T17:25:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-usa-13-milioni-di-dollari-per-vertenza-giudiziaria-su-prescrizione-farmaci-oftalmici/ 2017-07-06T17:50:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-con-purdue-university-per-ricerca-biomedica/ 2017-07-07T10:14:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-accordo-con-beigene-e-la-cina-e-sempre-piu-vicina/ 2017-07-07T10:34:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-arriva-in-italia-biosimilare-di-infliximab/ 2017-07-07T12:53:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-opdivo-vince-il-derby-con-yervoy-per-il-trattamento-del-melanoma/ 2017-07-07T13:54:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-lancia-navio-piattaforma-chirurgica-palmare/ 2017-07-07T14:09:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uc-san-diego-da-antiasmatico-fuori-brevetto-possibile-trattamento-diabete/ 2017-07-07T15:46:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-suprema-corte-uk-no-a-generici-alimta-tumore-al-polmone/ 2017-07-10T15:52:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-lancia-in-italia-miniserie-web-e-cambia-regole-della-comunicazione-digitale/ 2017-07-10T11:08:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-stop-allaccordo-con-capricorn-per-terapia-cardiovascolare-con-staminali/ 2017-07-10T10:08:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdc-al-vertice-arriva-la-vaccinista-brenda-fitzgerald/ 2017-07-10T10:42:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-premio-zanibelli-100-opere-in-concorso/ 2017-07-10T12:14:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-da-ce-ok-a-cenegermin-cheratite-farmaco-biotech-basato-su-ngf/ 2017-07-10T15:46:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-bene-tisagenlecleucel-leucemia-negli-studi-clinici-panel-fda-valuta-sicurezza/ 2017-07-11T09:39:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-malattie-rare-abpi-contesta-regole-del-governo-su-prezzi-farmaci/ 2017-07-11T10:16:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-rilancia-la-sfida-alla-disabilita-al-via-il-contest-maketocare/ 2017-07-11T12:08:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-richiede-a-fda-programma-ind-per-shp654-emofilia/ 2017-07-11T12:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paesi-in-via-di-sviluppo-big-data-per-contrastare-malattie-e-le-aziende-ci-credono/ 2017-07-11T14:29:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-india-il-lungo-percorso-per-riconquistare-la-fiducia-fda/ 2017-07-11T15:35:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-gabbie-elettroniche-contro-il-virus-zika/ 2017-07-12T13:32:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gran-bretagna-al-via-inchiesta-su-caso-sangue-infetto/ 2017-07-12T16:33:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-alert-su-zimbryta-biogen/ 2017-07-12T16:48:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceo-doro-ecco-i-primi-dieci/ 2017-07-12T17:06:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-emicizumab-emofilia-in-studio-fase-tre/ 2017-07-12T17:23:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-ce-approva-dimetilfumarato-psoriasi/ 2017-07-12T17:47:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-sede-ema-amsterdam-e-copenaghen-calano-gli-assi/ 2017-07-13T15:45:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomedicale-italiano-a-verona-una-nuova-vetrina/ 2017-07-13T17:16:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-fumata-bianca-il-nuovo-ceo-e-pascal-soriot/ 2017-07-13T17:14:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertx-arriva-in-italia-orkambi-fibrosi-cistica/ 2017-07-13T16:35:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-da-panel-fda-a-tisagenlecleucel-leucemia/ 2017-07-13T16:47:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saunders-allergan-no-al-botox-per-i-teenagers/ 2017-07-13T16:50:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-gioca-danticipo-con-produttori-generici-di-cialis-solo-a-fine-2018/ 2017-07-14T12:30:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-form-483-a-meridian-bioscience-per-dispositivi-piombemia/ 2017-07-14T12:47:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-nuovi-dati-a-favore-di-kyprolis-mieloma-multiplo/ 2017-07-14T12:55:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-raccomanda-zanzariera-basf-per-prevenzione-malaria/ 2017-07-14T13:22:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clinical-oriented-e-con-portfolio-diversificato-ecco-la-pharma-che-ama-il-digital/ 2017-07-14T14:00:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-efpia-a-rischio-fornitura-farmaci-salvavita/ 2017-07-14T14:36:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-con-disco-verde-fda-per-tremfya-si-apre-il-mercato-della-psoriasi/ 2017-07-17T13:24:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-gilead-tesaro-non-e-un-obiettivo/ 2017-07-17T13:49:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-il-silenzio-su-soriot-costa-tre-miliardi-di-sterline/ 2017-07-17T17:42:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-biosimilari-di-avastin-ed-herceptin-roche/ 2017-07-17T14:16:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-qrativ-start-up-di-mayo-clinic-usera-lintelligenza-artificiale/ 2017-07-17T16:11:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-blue-control-psoriasi-lieve-arriva-in-usa/ 2017-07-17T16:48:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-corte-dappello-brevetto-velcade-ancora-valido-in-usa/ 2017-07-18T12:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-cede-obagi-medical-per-190-milioni-di-dollari-a-fondo-dinvestimento/ 2017-07-18T16:50:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-da-antitrust-ue-accusa-di-patto-pay-for-delay-con-cephalon/ 2017-07-18T13:18:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-maroni-pronto-il-dossier/ 2017-07-18T14:14:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-fallisce-ancora-abrogazione-obamacare-al-senato/ 2017-07-18T16:58:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-leadership-nellartrite-con-cosentyx-e-i-biosimilari-di-enbrel-remicade-e-humira/ 2017-07-18T15:57:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-melazzioini-aifa-visita-lo-stabilimento-di-campoverde-di-aprilia/ 2017-07-18T15:56:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-dati-aifa-testimoniano-sicurezza-vaccini/ 2017-07-19T17:59:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-premiata-per-il-miglior-work-life-balance/ 2017-07-19T14:54:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q2-sotto-le-aspettative-bene-stelara-fiducia-in-tremfya/ 2017-07-19T16:34:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-da-oggi-accesso-online-ai-dati-sulle-segnalazioni-avverse/ 2017-07-19T16:49:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q2-in-linea-con-le-attese-alcon-sugli-scudi/ 2017-07-19T17:10:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-biotechnology-fda-approva-neratinib-tumore-al-seno/ 2017-07-19T17:22:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-apre-al-rimborso-dei-farmaci-importati/ 2017-07-20T19:27:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-arriva-in-italia-la-pegasparaginasi/ 2017-07-20T19:34:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-bene-le-combo-per-la-fibrosi-cistica-nel-2018-gli-studi-di-fase-avanzata/ 2017-07-20T19:46:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-schwabe-pharma-italia-omeopatia/ 2017-07-20T19:51:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/omeoimprese-dal-2019-gli-omeopatici-nel-prontuario-farmaceutico-nazionale/ 2017-07-20T20:04:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-da-fda-a-vosevi-la-triplice-terapia-contro-lepatite-c/ 2017-07-20T20:14:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-ilaria-piuzzi-a-capo-della-comunicazione/ 2017-07-21T12:47:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-partnership-con-ablynx-per-farmacki-immunologici/ 2017-07-21T16:12:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-apre-le-porte-agli-under-18-nelle-attivita-dei-comitati-e-delle-commissioni/ 2017-07-21T13:30:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-per-milano-tifano-governo-parlamento-e-farmindustria/ 2017-07-21T14:39:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-usa-cambio-di-sede-per-la-ricerca-e-sviluppo-vaccini/ 2017-07-21T15:34:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ironwood-funziona-candidato-contro-gerd-nei-pazienti-non-responder-ad-altre-terapie/ 2017-07-21T15:36:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-da-chmp-a-dupilumab-dermatite-atopica/ 2017-07-24T16:40:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ecco-la-ricetta-walmsley/ 2017-07-24T16:58:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-rydapt-leucemia-ce-lok-del-chmp/ 2017-07-24T17:09:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-francese-allema-con-farmaco-di-medicina-molecolare-nucleare/ 2017-07-24T17:17:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-farmaceutici-la-ce-da-il-via-libera-a-trimbow-bpco/ 2017-07-24T17:28:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-gentiloni-una-partita-da-non-perdere/ 2017-07-24T17:36:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-le-risposte-di-gilead-e-gsk-la-scommessa-di-johnson/ 2017-07-25T16:23:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merck-parere-positivo-da-chmp-per-bavencio-carcinoma-a-cellule-di-merkel/ 2017-07-25T17:26:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-bene-triplice-terapia-hiv-in-due-studi-fase-iii/ 2017-07-25T16:19:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-congela-antidolorifico-a-base-di-oppiodi-e-si-riaccende-il-dibattito-negli-usa/ 2017-07-25T16:45:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-doppia-raccomandazione-del-chmp-per-atezolizumab/ 2017-07-25T16:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-diasorin-il-portafolgio-immunodiagnostico-elisa-di-siemens-healthineers/ 2017-07-25T17:21:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-biosurfaces-per-device-malattie-gastrointestinali/ 2017-07-26T14:53:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-talz-psoriasi-trascina-il-q2/ 2017-07-27T11:57:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genocea-efficace-vaccino-biotech-contro-herpes-genitale/ 2017-07-26T16:07:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tetraphase-eravaciclina-raggiunge-endpoint-studio-presto-allesame-dellema/ 2017-07-26T16:27:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-omeopatici-la-gran-bretagna-non-li-rimborsa-piu/ 2017-07-26T16:35:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-e-dompe-accordo-strategico-per-commercializzazione-zalmoxis-leucemia/ 2017-07-26T16:49:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-al-via-la-cura-dimagrante-di-emma-walmsley/ 2017-07-27T16:11:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-studio-mystic-tumore-al-polmone-non-raggiunge-endpoint-primario/ 2017-07-27T16:21:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cochlear-nuova-protesi-audiologica-connette-direttamente-ai-dispositivi-apple/ 2017-07-27T16:38:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-hra-pharma-il-brand-compeed/ 2017-07-27T16:48:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dynavax-dubbi-fda-su-vaccino-contro-epatite-b/ 2017-07-27T17:01:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/edward-lifesciences-le-valvole-thvt-fanno-volare-il-q2/ 2017-07-27T17:07:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-come-sta-cambiando-il-mercato-dei-generici-india-e-cina-in-finestra/ 2017-07-28T15:41:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ottimo-q2-ma-quanto-costera-il-cyber-attacco-di-giugno/ 2017-07-31T11:27:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbivie-ok-da-ce-a-maviret-epatite-c/ 2017-08-04T14:46:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-q2-le-vendite-superano-gli-8-miliardi-di-euro/ 2017-07-31T14:20:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-fda-breakthrough-therapy-designation-per-durvalumab-tumore-al-polmone/ 2017-08-01T11:16:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/the-lancet-italia-sede-naturale-dellema-post-brexit/ 2017-08-01T13:30:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-ingelheim-q2-positivo-grazie-anche-allanimal-health/ 2017-08-02T12:41:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgeneagios-fda-approva-idhifa-leucemia-mieloide-acuta/ 2017-08-02T14:24:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-per-acalabrutinib-linfoma-mantellare-breakthrough-designation-e-priority-review-da-fda/ 2017-08-02T14:20:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-panel-fda-respinge-sirukumab-artrite-reumatoide/ 2017-08-03T13:37:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-pharma-india-verso-il-disclosure-code/ 2017-08-03T13:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-q2-positivo-botox-trascina-ancora-le-vendite/ 2017-08-04T14:39:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-dopo-quello-della-ce-ok-per-maviret-da-fda/ 2017-08-04T14:49:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oxford-biomedica-leadership-con-novartis-nella-terapia-car-t/ 2017-08-28T12:31:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-anche-leuropa-dice-si-a-kisqali-tumore-del-seno/ 2017-08-28T12:57:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-fda-estende-victoza-diabete-alla-prevenzione-cardiovascolare/ 2017-08-28T13:18:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adams-fda-approva-gocovri-trattamento-per-discinesia-da-parkinson/ 2017-08-28T14:02:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nuovo-dati-a-sostegno-dellestensione-di-brilinta/ 2017-09-08T13:22:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-bene-combo-xarelto-aspirina-primo-colpo-dopo-stop-monsanto/ 2017-08-29T11:04:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nuovo-accordo-con-ue-ed-ema-per-informazioni-su-attivita-ispettive/ 2017-08-29T12:01:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-astrazeneca-stringe-partnership-per-uso-intelligenza-artificiale/ 2017-08-29T12:39:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisita-kite-pharma-e-gilead-entra-nel-mercato-delle-terapie-car-t/ 2017-08-29T14:31:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicines-co-da-fda-ok-allantibiotico-vabomere/ 2017-08-30T12:40:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tekeda-partnership-contro-il-parkinson/ 2017-08-30T13:38:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-la-commissione-europea-approva-cladribina-compresse/ 2017-08-30T13:44:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-report-governo-uk-potenziare-investimenti-nel-farmaceutico/ 2017-08-31T13:55:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-in-studio-fase-iii-canakinumab-efficace-nel-cardiovascolare-e-nel-tumore-del-polmone/ 2017-08-31T14:49:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-in-autunno-stretta-sulla-medicina-rigenerativa/ 2017-08-31T14:47:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stada-claudio-albrecht-nuovo-ceo-e-il-quarto-in-un-anno/ 2017-09-01T12:52:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-bene-studi-pacific-e-flaura-tumore-al-polmone/ 2017-09-01T13:18:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-lonu-teme-per-la-tenuta-socio-sanitaria-fari-accesi-sui-diritti-delle-persone-disabili/ 2017-09-01T14:15:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-e-biocon-fda-rinvia-al-3-dicembre-decisione-su-biosimilare-herceptin-roche/ 2017-09-04T10:40:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nice-respinge-faslodex-il-4-ottobre-nuovo-pronunciamento/ 2017-09-04T13:48:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-fda-estende-indicazioni-tegaderm-a-infezioni-catetere-correlate/ 2017-09-04T13:30:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gileadnovartis-testa-a-testa-nella-sfida-car-t/ 2017-09-04T14:20:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otonomy-fallisce-studio-per-farmaco-malattia-di-meniere/ 2017-09-04T14:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-disco-verde-fda-per-mylotarg-leucemia-mieloide-acuta/ 2017-09-04T15:17:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-il-nuovo-ceo-e-vas-narasimhan/ 2017-09-05T17:56:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-punta-sullemofilia-a-fda-richiesta-per-candidato-a-lunga-durata-dazione/ 2017-09-05T13:00:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daichii-sankyo-fine-della-collaborazione-con-charleston-per-candidato-dolore/ 2017-09-05T13:57:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-premio-zanibelli-ecco-la-terna-dei-finalisti/ 2017-09-05T15:06:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/destiny-pharma-scommette-su-antibiotico-ultima-generazione-e-firma-accordo-con-la-cina/ 2017-09-05T15:22:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adherium-ok-fda-a-inalatore-per-symbicort-astrazeneca/ 2017-09-05T15:38:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-aifa-approva-rimborsabilita-di-venclyxto-venetoclax/ 2017-09-06T13:08:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-riprende-il-dibattito-negli-usa/ 2017-09-06T13:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-dipartimento-giustizia-usa-per-vicenda-victoza/ 2017-09-06T14:09:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-vende-la-bu-consumer/ 2017-09-06T14:33:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-salute-e-smart-working-nel-nuovo-accordo-integrativo/ 2017-09-06T14:52:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-u-s-army-si-sfila-da-collaborazione-su-vaccino-contro-zika-virus/ 2017-09-06T16:19:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-lancia-videogioco-per-giovani-pazienti-con-emofilia/ 2017-09-07T15:45:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-alecensa-tumore-al-polmone-convince-nel-trial/ 2017-09-07T16:44:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-kymriah-la-vera-innovazione-che-va-oltre-laccessibilita/ 2017-09-07T16:50:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/verastem-duvelisib-linfoma-raggiunge-obiettivo-studio-entro-meta-2018-domanda-fda/ 2017-09-07T17:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-usa-riprende-loccupazione/ 2017-09-07T17:08:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-la-fda-decide-su-volanesorsen-ionis/ 2017-09-07T17:18:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-combo-opdivo-yervoy-centra-obiettivo-prima-del-tempo-nel-tumore-renale/ 2017-09-11T15:46:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-warning-letter-a-produttore-di-oppiodi-e-scoppia-la-polemica/ 2017-09-08T14:21:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-problemi-per-epipen-interviene-fda/ 2017-09-08T14:30:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-priority-review-per-emicizumab-nellemofilia-a-con-inibitori/ 2017-09-08T15:28:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lillly-dal-2018-via-ai-licenziamenti-se-ne-prevedono-3500/ 2017-09-08T15:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-celgene-stop-della-fda-a-cinque-trials-su-combo-con-imfinzi/ 2017-09-08T16:47:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tagrisso-nuovo-standard-di-cura-per-tumore-al-polmone/ 2017-09-11T10:50:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-in-cinque-anni-31-molecole-innovative-contro-il-cancro/ 2017-09-11T16:05:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-pronto-test-ematico-per-personalizzare-terapie-oncologiche/ 2017-09-11T12:39:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-con-keytruda-rischio-di-morte-ridotto-del-30-per-cento-nel-carcinoma-uroteliale/ 2017-09-11T14:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-vemurafenib-piu-efficace-del-placebo-nella-dfs/ 2017-09-11T15:39:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-kare-shultz-e-il-nuovo-ceo-una-carriera-tra-lundbeck-e-novo-nordisk/ 2017-09-12T10:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-con-abemaciclib-tumore-al-seno-inizia-il-rilancio/ 2017-09-12T10:54:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-amgen-bene-tezepelumab-biologico-per-lasma/ 2017-09-12T12:24:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-breakthrough-therapy-per-cemiplimab-carcinoma-cutaneo/ 2017-09-12T12:44:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-e-regione-puglia-insieme-per-progetto-di-assessment-in-oncoematologia/ 2017-09-12T14:36:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-efficace-anche-nel-tumore-allo-stomaco/ 2017-09-12T15:13:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-gottlieb-trial-piu-snelli-per-migliorare-i-processi-regolatori-dei-farmaci/ 2017-09-13T14:55:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-pirfenidone-fibrosi-polmonare-sicuro-in-associazione-e-in-monoterapia/ 2017-09-13T15:13:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-gates-120-milioni-di-dollari-per-ricerca-vaccini/ 2017-09-13T15:33:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-mosquirix-testato-in-quattro-formulazioni/ 2017-09-13T15:46:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-il-nodo-e-sui-contributi-alle-assicurazioni/ 2017-09-13T16:46:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-arriva-in-italia-nuovo-mezzo-di-contrasto-per-rm/ 2017-09-13T16:55:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-panel-fda-raccomanda-vaccino-shingrix-herpes-zoster-agli-adulti-over-50/ 2017-09-14T16:03:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-11-milioni-di-dollari-per-piattaforma-trial-clinici/ 2017-09-14T13:49:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-cede-il-primo-brand-il-contraccettivo-paragard-passa-a-copper/ 2017-09-14T15:59:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-dupilumab-raggiunge-endpoint-in-studio-sullasma/ 2017-09-14T14:37:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bridgebio-pharma-135-milioni-per-ricerca-sulle-malattie-genetiche/ 2017-09-14T15:46:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-prezzi-dei-farmaci-una-lettera-a-jama-accende-i-fari-su-un-ormone/ 2017-09-14T15:01:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depuy-fda-autorizza-impianti-in-titanio-3d-per-chirurgia-maxillo-facciale/ 2017-09-15T10:28:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-accordo-con-imperial-college-per-chirurgia-del-ginocchio/ 2017-09-15T10:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuove-prospettive-per-baricitinib-nel-trattamento-delleczema/ 2017-09-15T11:01:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ok-da-fda-a-mvasi-biosimilare-di-avastin-roche/ 2017-09-15T16:34:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-parte-la-sperimentazione-del-vaccino-contro-la-dengue/ 2017-09-15T13:30:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-astellas-xtandi-cancro-alla-prostata-aumenta-i-tassi-di-sopravvivenza/ 2017-09-18T16:10:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biopis-ok-ema-a-ontruzant-biosimilare-di-herceptin-roche/ 2017-09-18T16:28:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-usa-calano-le-iscrizioni-ad-aca-aumentano-i-premi-delle-assicurazioni/ 2017-09-18T12:33:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-primo-si-dellema-a-tripla-combo-per-bpco/ 2017-09-18T16:44:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ce-approva-rivaroxaban-in-associazione-ad-antiaggregante-piastrinico-fibrillazione-atriale/ 2017-09-18T14:35:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-chmp-raccomanda-tremfya-psoriasi/ 2017-09-18T15:30:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-nel-maryland-prima-legge-contro-rincaro-prezzo-farmaci/ 2017-09-18T16:42:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-sempre-piu-forte-la-concorrenza-dei-biosimilari/ 2017-09-19T11:01:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gates-foundation-40-milioni-di-dollari-per-sviluppo-farmaci-contro-malattie-infettive/ 2017-09-19T11:14:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-da-fda-approvazione-accelerata-per-copanlisib-linfoma/ 2017-09-19T12:31:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-vende-ancora-dopo-paragard-ceduto-lintero-asset-salute-femminile/ 2017-09-19T13:00:07+00:00 monthly 0.2